| UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| FORM 10-K                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| x  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended April 30, 2010or¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ___________ to ___________ Commission file number:  001-05865                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Gerber Scientific, Inc.(Exact name of registrant as specified in its charter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Connecticut(State or other jurisdiction of incorporation or organization)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   | 06-0640743(I.R.S. Employer Identification No.)  |
| 83 Gerber Road West, South Windsor, Connecticut(Address of principal executive offices)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   | 06074(Zip Code) |
|  Registrant's telephone number, including area code:  (860) 644-1551                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Securities registered pursuant to Section 12(b) of the Act:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Title of each class                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |   | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   | New York Stock Exchange |
| Securities registered pursuant to Section 12(g) of the Act:  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ¨   No þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ¨   No þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ   No ¨                                                                                                                                                                                                                                                                                                                                                                                     |
| Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes ¨   No ¨                                                                                                                                                                                                                                                                                                                                                                              |
| Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  o                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.  Large accelerated filer ¨               Accelerated filer þ                         Non-accelerated filer ¨                   Smaller reporting company ¨  |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12-b2 of the Act.)     Yes ¨   No þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| The aggregate market value of Gerber Scientific, Inc. common stock held by non-affiliates as of October 31, 2009, which was the last business day of the registrant's most recently completed second fiscal quarter, based on the reported closing price of the common stock on the New York Stock Exchange on such date, was approximately $110,262,620.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 25,125,929 shares of common stock of the registrant were outstanding as of May 31, 2010, exclusive of treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| DOCUMENTS INCORPORATED BY REFERENCE:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Portions of the 2010 definitive Proxy Statement for the 2010 annual meeting of shareholders of the registrant, which is expected to be filed within 120 days following the end of the fiscal year covered by this report, are incorporated by reference into Part III hereof.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

----

| GERBER SCIENTIFIC, INC.Index to Annual Reporton Form 10-KFiscal Year Ended April 30, 2010 |
|-------------------------------------------------------------------------------------------|
| PART I                                                                                    | PAGE |
|                                                                                      |   |   |
| Item 1.                                                                                   | Business | 4-12 |
| Item 1A.                                                                                  | Risk Factors | 12-19 |
| Item 1B.                                                                                  | Unresolved Staff Comments | 19 |
| Item 2                                                                                    | Properties | 20 |
| Item 3.                                                                                   | Legal Proceedings | 20 |
| Item 4.                                                                                   | (Removed and Reserved) | 20 |
|                                                                                      | Executive Officers of the Registrant | 21 |
|                                                                                      |   |   |
| PART II                                                                                   |   |
|                                                                                      |   |   |
| Item 5.                                                                                   | Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 22-24 |
| Item 6.                                                                                   | Selected Financial Data | 25 |
| Item 7.                                                                                   | Management's Discussion and Analysis of Financial Condition and Results of Operations | 26-44 |
| Item 7A.                                                                                  | Quantitative and Qualitative Disclosures About Market Risk | 44 |
| Item 8.                                                                                   | Financial Statements and Supplementary Data | 45 |
| Item 9.                                                                                   | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure | 45 |
| Item 9A.                                                                                  | Controls and Procedures | 45 |
| Item 9B.                                                                                  | Other Information | 45 |
|                                                                                      |   |   |
| PART III                                                                                  |   |
|                                                                                      |   |   |
| Item 10.                                                                                  | Directors, Executive Officers and Corporate Governance | 46 |
| Item 11.                                                                                  | Executive Compensation | 46 |
| Item 12.                                                                                  | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 46 |
| Item 13.                                                                                  | Certain Relationships and Related Transactions, and Director Independence | 46 |
| Item 14.                                                                                  | Principal Accounting Fees and Services | 46 |
|                                                                                      |   |   |
| PART IV                                                                                   |   |
|                                                                                      |   |   |
| Item 15.                                                                                  | Exhibits, Financial Statement Schedules | 47-88 |
|                                                                                      |   |   |
| Signatures                                                                                | 89 |

----

----

PART I

ITEM 1.  BUSINESS

----

|                                     |                                                                  | For the fiscal year ended April 30, 2010 |
|------------------------------------------|-----------------------------------------------------------------------|------------------------------------------|
| Operating Segment                        | Principal Business Unit                                               | Revenue (in millions)               |   | Percent ofRevenue |
| Sign Making and Specialty Graphics  | Gerber Scientific Products, Gerber  Innovations and Spandex |                                     | $ | 257.2 |   |   |   | 56 | % |
| Apparel and Industrial                   | Gerber Technology                                                     |                                     |   | 155.1 |   |   |   | 34 | % |
| Ophthalmic Lens Processing               | Gerber Coburn                                                         |                                     |   | 46.1 |   |   |   | 10 | % |
|                                     |                                                                  |                                     | $ | 458.4 |   |   |   | 100 | % |

----

----

----

| ·   | conceptual design, advanced CAD pattern-making, and marking and nesting software for sewn products; |
|--------------------|-----------------------------------------------------------------------------------------------------|

| ·   | pattern design digitizers and large format plotters; |
|--------------------|------------------------------------------------------|

| ·   | CAM material spreading and single- and multi-ply cutting systems; |
|--------------------|-------------------------------------------------------------------|

| ·   | product lifecycle management, or "PLM," and product data management, or "PDM," software; |
|--------------------|------------------------------------------------------------------------------------------|

| ·   | precision laser-based templating and inspection solutions; |
|--------------------|------------------------------------------------------------|

| ·   | aftermarket supplies, including spare parts and consumable materials; and |
|--------------------|---------------------------------------------------------------------------|

| ·   | customer training, technical support and comprehensive maintenance and specialized support services. |
|--------------------|------------------------------------------------------------------------------------------------------|

----

----

----

|                               | April 30, |
|------------------------------------|-----------|
| In thousands                       |      | 2010 |   |   | 2009 |   |
| Sign Making and Specialty Graphics |      | $ | 1,007 |   |   | $ | 1,636 |   |
| Apparel and Industrial             |      |   | 25,646 |   |   |   | 21,800 |   |
| Ophthalmic Lens Processing         |      |   | 1,550 |   |   |   | 1,200 |   |
|                               |      | $ | 28,203 |   |   | $ | 24,636 |   |

----

ITEM 1A.  RISK FACTORS

----

| ·   | the pursuit of ultimately unconsummated acquisitions and the integration of acquired businesses could significantly strain management, financial and other resources and divert limited resources from regular operations; |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | acquisitions may not have an immediate positive impact on Gerber's cash flows or results of operations due to transaction-related expenses or higher operating and administrative expenses that may be incurred during the integration period immediately following the acquisitions; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Gerber may not be able to achieve the synergies and cost savings anticipated to result from any acquisition; |
|--------------------|--------------------------------------------------------------------------------------------------------------|

| ·   | Gerber's operating and financial systems and controls and information services may not be compatible with those of acquired companies or adequate to support integration efforts, and any steps taken to improve these systems and controls may not be sufficient; |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | acquisitions could increase Gerber's need for qualified personnel, who may not be available; and |
|--------------------|--------------------------------------------------------------------------------------------------|

| ·   | acquired businesses may have unexpected liabilities and contingencies, which could be significant. |
|--------------------|----------------------------------------------------------------------------------------------------|

| ·   | general geopolitical risks, such as political and economic instability and changes in diplomatic and trade relationships; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------|

| ·   | imposition of or increases in currency exchange controls; |
|--------------------|-----------------------------------------------------------|

| ·   | potential inflation in the applicable foreign economies; |
|--------------------|----------------------------------------------------------|

| ·   | imposition of or increases in import duties and other tariffs on products; and |
|--------------------|--------------------------------------------------------------------------------|

| ·   | imposition of or increases in foreign taxation of earnings and withholding on payments received from subsidiaries. |
|--------------------|--------------------------------------------------------------------------------------------------------------------|

----

| ·   | make it more difficult for Gerber to satisfy its financial obligations; |
|--------------------|-------------------------------------------------------------------------|

| ·   | require Gerber to dedicate a substantial portion of its cash flow from operations to payments on its indebtedness; |
|--------------------|--------------------------------------------------------------------------------------------------------------------|

| ·   | limit Gerber’s ability to react to changes to the economy or in its business or industry; and |
|--------------------|-----------------------------------------------------------------------------------------------------|

| ·   | place Gerber at a competitive disadvantage relative to companies that have less indebtedness. |
|--------------------|-----------------------------------------------------------------------------------------------|

| ·   | incur additional indebtedness, create liens and make investments; |
|--------------------|-------------------------------------------------------------------|

| ·   | pay dividends on or redeem or repurchase capital stock, and issue or sell stock of subsidiaries; and |
|--------------------|------------------------------------------------------------------------------------------------------|

| ·   | engage in sale-leaseback transactions, sell assets and engage in mergers, sales, acquisitions and consolidations. |
|--------------------|-------------------------------------------------------------------------------------------------------------------|

----

----

| ·   | changes in general economic conditions and specific conditions in industries in which Gerber's businesses operate that can result in the deferral or reduction of purchases by end-use customers; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | changes in the level of global corporate spending on technologies due to such economic conditions; |
|--------------------|----------------------------------------------------------------------------------------------------|

| ·   | the effects of terrorist activity and international conflicts, which could lead to business interruptions; |
|--------------------|------------------------------------------------------------------------------------------------------------|

| ·   | the size and timing of significant orders, which can be non-recurring; |
|--------------------|------------------------------------------------------------------------|

| ·   | product configuration and mix; |
|--------------------|--------------------------------|

| ·   | market acceptance of new products and product enhancements; |
|--------------------|-------------------------------------------------------------|

| ·   | announcements, introductions and transitions of new products by Gerber or Gerber's competitors; |
|--------------------|-------------------------------------------------------------------------------------------------|

| ·   | deferrals of customer orders in anticipation of new products or product enhancements introduced by Gerber or Gerber's competitors; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------|

| ·   | changes in pricing in response to competitive pricing actions; |
|--------------------|----------------------------------------------------------------|

| ·   | supply constraints; |
|--------------------|---------------------|

| ·   | the level of expenditures on research and development and sales and marketing programs; |
|--------------------|-----------------------------------------------------------------------------------------|

| ·   | Gerber's ability to achieve targeted cost reductions; |
|--------------------|-------------------------------------------------------|

| ·   | rising interest rates; and |
|--------------------|----------------------------|

| ·   | costs associated with excess capacity or idle facilities. |
|--------------------|-----------------------------------------------------------|

----

----

----

ITEM 1B.  UNRESOLVED STAFF COMMENTS

----

ITEM 2.  PROPERTIES

| Type of Facility                                                     | Location                                                                                                                                                                                                    | Square Feet |
|----------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
|                                                                 |                                                                                                                                                                                                        |        |
| Corporate headquarters / manufacturing / office (L) (1,3)            | South Windsor, Connecticut                                                                                                                                                                                  | 250,000     |
| Manufacturing / office (O) (1,2,3)                                   | Tolland, Connecticut                                                                                                                                                                                        | 224,000     |
| Manufacturing / warehouse / office (L) (1,2,3)                       | Manchester, Connecticut                                                                                                                                                                                     | 118,000     |
| Manufacturing / office (O) (1)                                       | Lancaster, England                                                                                                                                                                                          | 125,000     |
| Manufacturing / office (L) (2)                                       | Ikast, Denmark                                                                                                                                                                                              | 39,000      |
| Manufacturing / office (O) (1)                                       | Achern, Germany                                                                                                                                                                                             | 56,000      |
| Warehouse / sales and service office (L) (1,4)                       | Bristol, England                                                                                                                                                                                            | 110,000     |
| Manufacturing / warehouses / sales and service offices (L) (1,2,3,4) | Various                                                                                                                                                                                                     | 540,000     |
| (O)                                                                  | Company-owned                                                                                                                                                                                               |
| (L)                                                                  | Leased                                                                                                                                                                                                      |
| (1)                                                                  | Sign Making and Specialty Graphics                                                                                                                                                                          |
| (2)                                                                  | Apparel and Industrial                                                                                                                                                                                      |
| (3)                                                                  | Ophthalmic Lens Processing                                                                                                                                                                                  |
| (4)                                                                  | As of April 30, 2010, the Company sublet 45,145 square feet in Bristol, England and 35,145 square feet in Toronto, Canada to independent third parties pursuant to subleases expiring over various periods. |

ITEM 3.  LEGAL PROCEEDINGS

ITEM 4.  (REMOVED AND RESERVED)

----

EXECUTIVE OFFICERS OF THE REGISTRANT

| Name                            | Age    | Positionand Date of Initial Appointment                                                                            | Principal Business Experience Since April 2005                                                                                                                                                                                                                                                                                                                                               |
|---------------------------------|--------|--------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Marc T. Giles                   | 54     | President and Chief Executive Officer (November 29, 2001)                                                          | ---                                                                                                                                                                                                                                                                                                                                                                                          |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Michael R. Elia                 | 51     | Executive Vice President, Chief Financial Officer (April 15, 2008) and Chief Accounting Officer (January 29, 2010) | Chief Financial Officer, Risk Management Solutions, Inc. (January 2008 – April 2008), a specialty service provider for the insured and alternative risk marketplace; Senior Vice President and Chief Financial Officer of FastenTech, Inc. (January 2004 - December 2007), a global metal products manufacturer                                                                        |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| James S. Arthurs                | 66     | Senior Vice President (September 30, 2002); President Asia-Pacific, Gerber Scientific, Inc. (February 1, 2005)     | ---                                                                                                                                                                                                                                                                                                                                                                                          |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Patricia L. Burmahl   | 48     | Senior Vice President, Global Human Resources (May 3, 2010)                                                        | Vice President, Worldwide Development HR, Pfizer (March 2007 – September 2008), a research-based pharmaceutical company; Vice President, Worldwide Research HR, Pfizer (January 2004 – February 2007)                                                                                                                                                                            |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Thomas P. Finn                  | 50     | Senior Vice President, Operations (February 15, 2010)                                                              | Executive VP, Operations Restructuring, Medis Technologies, Inc (January 2009 – May 2009), a fuel cell technology company; Independent Consultant, (January 2007 – January 2010), VP Supply Chain and Chief Supply Chain Officer – Asia Pacific & China, Lucent Technologies, Inc. (March 2000 – December 2006), a manufacturer of telecommunications equipment. |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| William V. Grickis, Jr.         | 59     | Senior Vice President and General Counsel (October 1, 2003); Secretary (November 20, 2003)                         | ---                                                                                                                                                                                                                                                                                                                                                                                          |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| John R. Hancock                 | 63     | Senior Vice President (December 7, 2001); President, Gerber Technology (February 1, 2005)                          | ---                                                                                                                                                                                                                                                                                                                                                                                          |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Alex F. Incera                  | 46     | President, Gerber Coburn (September 25, 2008)                                                                      | General Manager, Gerber Coburn (January 2008 – September 24, 2008); Executive Director of Marketing, Gerber Coburn (October 2006 – January 2008); Vice President of Engineering, Gerber Coburn (March 1999-October 2006)                                                                                                                                          |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Rodney W. Larson                | 52     | Senior Vice President (May 1, 2007); President, Spandex (July 1, 2007)                                             | President, Gerber Coburn (March 2006 – July 2007); Independent consultant (2005 – April 2007); VP, Sales and Marketing, Key Technology (2003 - 2005), developer of automated inspection, sorting and material conveying solutions for process industries                                                                                                                         |
|                            |   |                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                         |
| Stephen P. Lovass               | 40     | Senior Vice President; President, Gerber Scientific Products (February 11, 2008)                                   | President, Gerber Coburn (July 1, 2007 – September 24, 2008); Vice President; President, Spandex (November 2006); Interim Group Managing Director, Spandex  (February 2005 - November 2006)                                                                                                                                                                                  |

----

PART II

ITEM 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND

                 ISSUER PURCHASES OF EQUITY SECURITIES

|           |   | High   |   |   | Low    |   |   | Close  |   |
|----------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
| Fiscal 2010    |   |   |   |   |   |   |   |   |   |   |
| First Quarter  |   | $      | 3.94   |   |   | $      | 2.16   |   |   | $ | 3.13 |   |
| Second Quarter |   | $      | 6.90   |   |   | $      | 3.03   |   |   | $ | 4.62 |   |
| Third Quarter  |   | $      | 5.44   |   |   | $      | 4.28   |   |   | $ | 4.90 |   |
| Fourth Quarter |   | $      | 8.03   |   |   | $      | 4.91   |   |   | $ | 7.20 |   |
| Fiscal 2009    |   |   |   |   |   |   |   |   |   |   |
| First Quarter  |   | $      | 12.64  |   |   | $      | 8.74   |   |   | $ | 11.87 |   |
| Second Quarter |   | $      | 12.00  |   |   | $      | 4.18   |   |   | $ | 4.78 |   |
| Third Quarter  |   | $      | 5.50   |   |   | $      | 1.79   |   |   | $ | 3.14 |   |
| Fourth Quarter |   | $      | 3.98   |   |   | $      | 1.65   |   |   | $ | 3.95 |   |

| Period                                     |   | (a)TotalNumberof Shares(or Units)Purchased |   |   | (b)AveragePricePaid perShare(or Unit) |   | (c)Total Number ofShares (or Units)Purchased as Partof PubliclyAnnounced Plansor Programs | (d)MaximumNumber (orApproximateDollar Value)of Shares (or Units)that May Yet BePurchased Under thePlans or Programs |
|--------------------------------------------|--------|--------------------------------------------|--------|--------|---------------------------------------|--------|-------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| February 1, 2010 – February 28, 2010 |   |                                       | ---    |   |                                  |   | ---                                                                                       |                                                                                                                | Not applicable | Not applicable |
| March 1, 2010 – March 31, 2010 (1)   |   |                                       | 40,469 |   |                                  | $      | 6.58                                                                                      |                                                                                                                | Not applicable | Not applicable |
| April 1, 2010 – April 30, 2010 (1)   |   |                                       | 6,990  |   |                                  | $      | 7.12                                                                                      |                                                                                                                | Not applicable | Not applicable |
|                                       |   |                                       | 47,459 |   |                                  | $      | 6.66                                                                                      |                                                                                                                | Not applicable | Not applicable |

----

|                              |   | Apr-05 |   |   | Apr-06 |   |   | Apr-07 |   |   | Apr-08 |   |   | Apr-09 |   |   | Apr-10 |   |
|-----------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
|                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Gerber Scientific, Inc.           |   |   | 100.00 |   |   |   | 146.47 |   |   |   | 141.38 |   |   |   | 130.93 |   |   |   | 55.79 |   |   |   | 101.69 |   |
| S&P Smallcap 600              |   |   | 100.00 |   |   |   | 131.39 |   |   |   | 141.45 |   |   |   | 128.65 |   |   |   | 89.99 |   |   |   | 132.99 |   |
| Dow Jones US Electronic Equipment |   |   | 100.00 |   |   |   | 139.60 |   |   |   | 148.15 |   |   |   | 154.59 |   |   |   | 106.25 |   |   |   | 167.72 |   |

----

----

ITEM 6.  SELECTED FINANCIAL DATA

|                                                                                           | For the Fiscal Years Ended April 30, |   |
|------------------------------------------------------------------------------------------------|--------------------------------------|--------|
| In thousands, except per share amounts                                                         |                                 | 2010   |   | 2009 |   | 2008 |   | 2007 |   |   | 2006 |   |
| Revenue                                                                                        |                                 | $      | 458,355 |   |   | $ | 498,940 |   |   | $ | 594,298 |   |   | $ | 536,375 |   |   | $ | 495,642 |   |
| Income from continuing operations before cumulative effect of a change in accounting principle |                                 | $      | 1,342 |   |   | $ | 4,801 |   |   | $ | 15,114 |   |   | $ | 13,992 |   |   | $ | 3,880 |   |
| Per common share:                                                                              |                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                                                          |                                 | $      | 0.05 |   |   | $ | 0.20 |   |   | $ | 0.64 |   |   | $ | 0.61 |   |   | $ | 0.17 |   |
| Diluted                                                                                        |                                 | $      | 0.05 |   |   | $ | 0.20 |   |   | $ | 0.64 |   |   | $ | 0.60 |   |   | $ | 0.17 |   |
| Net (loss) income                                                                              |                                 | $      | (1,458 | ) |   | $ | 2,236 |   |   | $ | 14,504 |   |   | $ | 13,508 |   |   | $ | 2,644 |   |
| Per common share:                                                                              |                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                                                          |                                 | $      | (0.06 | ) |   | $ | 0.09 |   |   | $ | 0.62 |   |   | $ | 0.59 |   |   | $ | 0.12 |   |
| Diluted                                                                                        |                                 | $      | (0.06 | ) |   | $ | 0.09 |   |   | $ | 0.61 |   |   | $ | 0.58 |   |   | $ | 0.12 |   |
| Total assets                                                                                   |                                 | $      | 351,877 |   |   | $ | 359,217 |   |   | $ | 378,539 |   |   | $ | 335,962 |   |   | $ | 310,480 |   |
| Long-term debt (includes current maturities)                                                   |                                 | $      | 45,000 |   |   | $ | 73,500 |   |   | $ | 42,000 |   |   | $ | 31,836 |   |   | $ | 37,120 |   |
| Shareholders' equity                                                                           |                                 | $      | 158,206 |   |   | $ | 148,302 |   |   | $ | 169,563 |   |   | $ | 144,481 |   |   | $ | 125,616 |   |

----

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS

                 OF OPERATIONS

| ·   | expected financial condition, future earnings, levels of growth, or other measures of financial performance, or the future size of market segments or geographic markets; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | economic conditions; |
|--------------------|----------------------|

| ·   | planned cost reductions; |
|--------------------|--------------------------|

| ·   | future cash flows and uses of cash and debt reduction strategies; |
|--------------------|-------------------------------------------------------------------|

| ·   | prospective product developments and business growth opportunities, as well as competitor product developments; |
|--------------------|-----------------------------------------------------------------------------------------------------------------|

| ·   | demand for products and services; |
|--------------------|-----------------------------------|

| ·   | methods of and costs associated with potential geographic expansion; |
|--------------------|----------------------------------------------------------------------|

| ·   | regulatory and market developments and the impact of such developments on future operating results; |
|--------------------|-----------------------------------------------------------------------------------------------------|

| ·   | potential impacts from credit market risk; |
|--------------------|--------------------------------------------|

| ·   | future effective income tax rates; |
|--------------------|------------------------------------|

| ·   | the outcome of contingencies; |
|--------------------|-------------------------------|

| ·   | the availability and cost of raw materials; and |
|--------------------|-------------------------------------------------|

| ·   | pension plan assumptions and future contributions. |
|--------------------|----------------------------------------------------|

|                                                                                                             | For the Fiscal Years Ended April 30, |   |
|------------------------------------------------------------------------------------------------------------------|------------------------------------------------|--------|
| In thousands                                                                                                     |                                           | 2010   |   |   | 2009 |   |   | 2008 |   |
| Sign Making and Specialty Graphics (Gerber Scientific Products, Gerber   Innovations and Spandex) |                                           | $      | 257,122 |   |   | $ | 282,420 |   |   | $ | 320,265 |   |
| Apparel and Industrial (Gerber Technology)                                                                       |                                           |   | 155,145 |   |   |   | 162,965 |   |   |   | 207,945 |   |
| Ophthalmic Lens Processing (Gerber Coburn)                                                                       |                                           |   | 46,088 |   |   |   | 53,555 |   |   |   | 66,088 |   |
| Consolidated revenue                                                                                        |                                           | $      | 458,355 |   |   | $ | 498,940 |   |   | $ | 594,298 |   |

----

|                                                      |   | For the Fiscal Years Ended April 30, |   |   |
|-----------------------------------------------------------|--------|------------------------------------------------|--------|--------|
|                                                      |   | 2010                                           |   |   |   | 2009 |   |   |   | 2008 |   |   |
| Gross profit margin                                       |   |                                           | 29.4   |   | % |   |   | 28.8 |   | %  |   |   | 30.1 |   | % |
| Selling, general and administrative ("SG&A") expenses |   |                                           | (23.1  | )      | % |   |   | (23.0 | ) | %  |   |   | (21.5 | ) | % |
| Research and development                                  |   |                                           | (4.0   | )      | % |   |   | (4.2 | ) | % |   |   | (4.4 | ) | % |
| Restructuring and other expenses                          |   |                                           | (0.7   | )      | % |   |   | (0.3 | ) | % |   |   | --- |   |   |
| Operating income                                          |   |                                           | 1.6    |   | % |   |   | 1.3 |   | %  |   |   | 4.2 |   | % |

----

|                                         | For the Fiscal Years Ended April 30, |   |
|----------------------------------------------|------------------------------------------------|--------|
| In thousands                                 |                                           | 2010   |   |   | 2009 |   |   | 2008 |   |
| Revenue                                      |                                           | $      | 458,355 |   |   | $ | 498,940 |   |   | $ | 594,298 |   |
| Cost of sales                                |                                           |   | 323,722 |   |   |   | 355,325 |   |   |   | 415,518 |   |
| Gross profit                                 |                                           |   | 134,633 |   |   |   | 143,615 |   |   |   | 178,780 |   |
| Selling, general and administrative expenses |                                           |   | 106,062 |   |   |   | 114,607 |   |   |   | 127,555 |   |
| Research and development                     |                                           |   | 18,517 |   |   |   | 21,123 |   |   |   | 26,187 |   |
| Restructuring and other expenses             |                                           |   | 2,654 |   |   |   | 1,168 |   |   |   | 250 |   |
| Operating income                             |                                           | $      | 7,400 |   |   | $ | 6,717 |   |   | $ | 24,788 |   |

----

|                           |   | For the Fiscal Years Ended April 30, |    |
|--------------------------------|--------|--------------------------------------|---------|
| In thousands                   |   | 2010                                 |    |   | 2009 |   |   | 2008 |   |
| Equipment and software revenue |   | $                                    | 119,105 |   | 26.0 | % |   | $ | 141,965 |   | 28.5 | % |   | $ | 196,303 |   | 33.0 | % |
| Aftermarket supplies revenue   |   |                                 | 274,334 |   | 59.8 | % |   |   | 285,818 |   | 57.2 | % |   |   | 324,591 |   | 54.6 | % |
| Service revenue                |   |                                 | 64,916  |   | 14.2 | % |   |   | 71,157 |   | 14.3 | % |   |   | 73,404 |   | 12.4 | % |
| Revenue                        |   | $                                    | 458,355 |   | 100.0 | % |   | $ | 498,940 |   | 100.0 | % |   | $ | 594,298 |   | 100.0 | % |

|          |   | For the Fiscal Years Ended April 30, |
|---------------|--------|--------------------------------------|
| In thousands  |   | 2010                                 |   |   | 2009 |   |   | 2008 |
| North America |   | $                                    | 153,877 |   | 33.6 | % |   | $ | 183,513 |   | 36.8 | % |   | $ | 174,305 |   | 29.3 | % |
| Europe        |   |                                 | 209,021 |   | 45.6 | % |   |   | 232,717 |   | 46.6 | % |   |   | 287,877 |   | 48.5 | % |
| Rest of World |   |                                 | 95,457 |   | 20.8 | % |   |   | 82,710 |   | 16.6 | % |   |   | 132,116 |   | 22.2 | % |
| Revenue       |   | $                                    | 458,355 |   | 100.0 | % |   | $ | 498,940 |   | 100.0 | % |   | $ | 594,298 |   | 100.0 | % |

----

|  In thousands                                   |   | April 30,2010 |   |   | April 30,2009 |   |
|------------------------------------------------------|--------|---------------|--------|--------|---------------|--------|
| Backlog:                                             |   |          |   |   |          |   |
|    Sign Making and Specialty Graphics |   | $             | 1,007  |   |          | $      | 1,636 |   |
|    Apparel and Industrial             |   |          | 25,646 |   |          |   | 21,800 |   |
|    Ophthalmic Lens Processing         |   |          | 1,550  |   |          |   | 1,200 |   |
|                                                 |   | $             | 28,203 |   |          | $      | 24,636 |   |

|                | For the Fiscal Years Ended April 30, |
|---------------------|------------------------------------------------|
| In thousands        | 2010                                           |   |   | 2009 |   | 2008 |   |
| Gross profit        | $                                              | 134,633 |   |   | $ | 143,615 |   | $ | 178,780 |   |
| Gross profit margin |                                           | 29.4 | % |   |   | 28.8 | % |   | 30.1 | % |

----

|                                         |   | For the Fiscal Years Ended April 30, |    |
|----------------------------------------------|--------|--------------------------------------|---------|
| In thousands                                 |   | 2010                                 |    |   | 2009 |   | Change |   | 2009 | 2008 | Change |   |
| Selling, general and administrative expenses |   | $                                    | 106,062 |   |   | $ | 114,607 |   | (7.5 | % | ) | $ | 114,607 | $ | 127,555 | (10.2 | % | ) |

|                                 |   | For the Fiscal Years Ended April 30, |   |
|--------------------------------------|--------|--------------------------------------|--------|
| In thousands                         |   | 2010                                 |   |   | 2009 |   | Change |   | 2009 | 2008 | Change |   |
| Research and development ("R&D") |   | $                                    | 18,517 |   |   | $ | 21,123 |   | (12.3 | % | ) | $ | 21,123 | $ | 26,187 | (19.3 | % | ) |

|                             | For the Fiscal Years Ended April 30, |   |
|----------------------------------|--------------------------------------|--------|
| In thousands                     |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Restructuring and other expenses |                                 | $      | 2,654 |   |   | $ | 1,168 |   |   | $ | 250 |   |

----

|                        | For the Fiscal Years Ended April 30, |   |
|-----------------------------|--------------------------------------|--------|
| In thousands                |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Other income (expense), net |                                 | $      | (1,366 | ) |   | $ | (2,804 | ) |   | $ | 264 |   |

|                                            | For the Fiscal Years Ended April 30, |   |
|-------------------------------------------------|--------------------------------------|--------|
| In thousands                                    |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Interest expense                                |                                 | $      | 4,160 |   |   | $ | 3,133 |   |   | $ | 3,895 |   |
| Weighted-average credit facility interest rates |                                 |   | 7.2 | % |   |   | 5.7 | % |   |   | 8.6 | % |

----

|               | For the Fiscal Years Ended April 30, |   |
|--------------------|--------------------------------------|--------|
|               |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Effective tax rate |                                 |   | 28.4 | % |   |   | (515.5 | )% |   |   | 28.6 | % |

----

|                    |   | For the Fiscal Years Ended April 30, |
|-------------------------|--------|--------------------------------------|
|                    |   | 2010                                 |   |   | 2009 |   |   | 2008 |
| In thousands            |   | GSP                                  |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                 |   | $                                    | 45,141 |   |   | $ | 211,981 |   |   | $ | 257,122 |   |   | $ | 57,460 |   |   | $ | 224,960 |   |   | $ | 282,420 |   |   | $ | 68,769 |   |   | $ | 251,496 |   |   | $ | 320,265 |   |
| Operating (loss) income |   | $                                    | (5,539 | ) |   | $ | 12,461 |   |   | $ | 6,922 |   |   | $ | (1,078 | )  |   | $ | 10,459 |   |   | $ | 9,381 |   |   | $ | 1,407 |   |   | $ | 11,656 |   |   | $ | 13,063 |   |

----

|                     | For the Fiscal Years Ended April 30, |   |
|--------------------------|--------------------------------------|--------|
| In thousands             |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Segment revenue          |                                 | $      | 155,145 |   |   | $ | 162,965 |   |   | $ | 207,945 |   |
| Segment operating income |                                 | $      | 18,342 |   |   | $ | 15,352 |   |   | $ | 29,177 |   |

----

|                     | For the Fiscal Years Ended April 30, |   |
|--------------------------|--------------------------------------|--------|
| In thousands             |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Segment revenue          |                                 | $      | 46,088 |   |   | $ | 53,555 |   |   | $ | 66,088 |   |
| Segment operating income |                                 | $      | 2,496 |   |   | $ | 3,365 |   |   | $ | 5,270 |   |

|                         | For the Fiscal Years Ended April 30, |   |
|------------------------------|--------------------------------------|--------|
| In thousands                 |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Corporate operating expenses |                                 | $      | 20,360 |   |   | $ | 21,381 |   |   | $ | 22,722 |   |

----

----

|                                                      |   | April 30, |    |
|-----------------------------------------------------------|--------|-----------|---------|
| In thousands except ratio amounts                         |   | 2010      |    |   | 2009 |   |
| Cash and cash equivalents                                 |   | $         | 11,305  |   |   | $ | 10,313 |   |
| Working capital                                           |   | $         | 76,549  |   |   | $ | 92,839 |   |
| Total debt                                                |   | $         | 45,000  |   |   | $ | 73,500 |   |
| Net debt (total debt less cash and cash equivalents) |   | $         | 33,695  |   |   | $ | 63,187 |   |
| Shareholders' equity                                      |   | $         | 158,206 |   |   | $ | 148,302 |   |
| Total capital (net debt plus shareholders' equity)        |   | $         | 191,901 |   |   | $ | 211,489 |   |
| Current ratio                                             |   | 1.85:1    |    |   | 2.02:1 |   |
| Net debt-to-total capital ratio                           |   |      | 17.6    | % |   |   | 29.9 | % |

|                                                 | For the Fiscal Years Ended April 30, |
|------------------------------------------------------|--------------------------------------|
| In thousands                                         |                                 |   | 2010 |   |   |   | 2009 |   |   | 2008 |   |
| Net cash provided by operating activities            |                                 | $ | 25,096 |   |   | $ | 9,774 |   | $ | 10,205 |   |
| Net cash provided by (used for) investing activities |                                 | $ | 4,535 |   |   | $ | (40,418 | ) | $ | (13,764 | ) |
| Net cash (used for) provided by financing activities |                                 | $ | (28,972 | ) |   | $ | 30,139 |   | $ | 7,986 |   |

----

----

| Total Funded Debt to Consolidated EBITDA Ratio |   | ABR Margin(basis points) |   |   | LIBOR Margin(basis points) |   |   | Commitment Fee (basis points) |   |
|------------------------------------------------|--------|--------------------------|--------|--------|----------------------------|--------|--------|-------------------------------|--------|
| 3.00x and greater                              |   |                     | 300.0  |   |                       |   | 400.0  |                          |   |   | 50.0 |   |
| 2.25x to less than 3.00x                       |   |                     | 225.0  |   |                       |   | 325.0  |                          |   |   | 50.0 |   |
| 1.50x to less than 2.25x                       |   |                     | 175.0  |   |                       |   | 275.0  |                          |   |   | 37.5 |   |
| 0.75x to less than 1.50x                       |   |                     | 137.5  |   |                       |   | 237.5  |                          |   |   | 25.0 |   |
| Less than 0.75x                                |   |                     | 100.0  |   |                       |   | 200.0  |                          |   |   | 25.0 |   |

| Twelve Month Period Ended    | Covenant       | Actual as of April 30, 2010 |
|------------------------------|----------------|-----------------------------|
| April 30, 2010               | Maximum 3.00:1 | 2.05:1                      |
| July 31, 2010 and thereafter | Maximum 3.00:1 | Not applicable              |

| Twelve Month Period Ended       | Covenant       | Actual as of April 30, 2010 |
|---------------------------------|----------------|-----------------------------|
| April 30, 2010                  | Minimum 2.25:1 | 3.69:1                      |
| July 31, 2010                   | Minimum 2.50:1 | Not applicable              |
| October 31, 2010 and thereafter | Minimum 3.00:1 | Not applicable              |

----

|                                        |   | Payments Due by Period |    |
|---------------------------------------------|--------|------------------------|---------|
| In thousands                                |   | Total                  |    | Less Than1 Year |   | 1-3 Years |   | 3-5 Years |   | More than5 Years |   |
| Long-term debt obligations                  |   | $                      | 45,000  | * |   | $ | --- |   |   | $ | 45,000 | * |   | $ | --- |   |   | $ | --- |   |
| Lease obligations                           |   |                   | 51,657  |   |   |   | 10,731 |   |   |   | 17,179 |   |   |   | 11,551 |   |   |   | 12,196 |   |
| Inventory and other purchase obligations    |   |                   | 14,428  |   |   |   | 12,869 |   |   |   | 1,559 |   |   |   | --- |   |   |   | --- |   |
| Qualified and non-qualified pension funding |   |                   | 7,441   |   |   |   | 1,371 |   |   |   | 1,193 |   |   |   | 1,242 |   |   |   | 3,635 |   |
| Total                                       |   | $                      | 118,526 |   |   | $ | 24,971 |   |   | $ | 64,931 |   |   | $ | 12,793 |   |   | $ | 15,831 |   |

----

----

----

ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

----

ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

ITEM 9A.  CONTROLS AND PROCEDURES

ITEM 9B.  OTHER INFORMATION

----

PART III

ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 11.  EXECUTIVE COMPENSATION

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14.  PRINCIPAL ACCOUNTING FEES AND SERVICES

----

PART IV

ITEM 15.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES

|                                                             |                                                                                                                                                                          | Page   |
|------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Management's Report on Internal Control over Financial Reporting | 50                                                                                                                                                                            |
| 1.                                                               | Financial Statements:                                                                                                                                                         |   |
|                                                             | Report of Independent Registered Public Accounting Firm                                                                                                                       | 51     |
|                                                             | Consolidated Statements of Operations for the fiscal years ended April 30, 2010, 2009 and 2008                                                                                | 52     |
|                                                             | Consolidated Balance Sheets as of April 30, 2010 and 2009                                                                                                                     | 53     |
|                                                             | Consolidated Statements of Cash Flows for the fiscal years ended April 30, 2010, 2009 and 2008                                                                                | 54     |
|                                                             | Consolidated Statements of Changes in Shareholders' Equity for each of the three fiscal years in the period ended April 30, 2010                                              | 55     |
|                                                             | Notes to Consolidated Financial Statements                                                                                                                                    | 56-88  |
|                                                             |                                                                                                                                                                          |
| 2.                                                               | Financial Statement Schedules                                                                                                                                                 |
|                                                             | All financial statement schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto. |
|                                                             |                                                                                                                                                                          |   |
| 3.                                                               | ExhibitsGerber Scientific, Inc. herewith files or incorporates herein the following exhibits:                                                                            |
| ExhibitNumber |  Exhibit Description                                                                                                                                                                                                                     |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          |                                                                                                                                                                                                                                          |
| 3.1           | Amended and Restated Certificate of Incorporation of Gerber Scientific, Inc. (incorporated herein by reference to Exhibit 3.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2004).                       |
|          |                                                                                                                                                                                                                                          |
| 3.2           | Amended and Restated By-laws of Gerber Scientific, Inc.  Filed herewith.                                                                                                                                                            |
|          |                                                                                                                                                                                                                                          |
| 4.1           | Form of common stock certificate of Gerber Scientific, Inc. (incorporated herein by reference to Exhibit 4.1 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2007).                                                |
|          |                                                                                                                                                                                                                                          |
| 10.1          | Gerber Scientific, Inc. Non-Employee Director's Stock Grant Plan, as amended and restated (incorporated herein by reference to Exhibit 10.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2006).         |
|          |                                                                                                                                                                                                                                          |
| 10.2          | Gerber Scientific, Inc. 1992 Non-Employee Director Stock Option Plan, as amended and restated (incorporated herein by reference to Exhibit 10.2 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 1999).             |
|          |                                                                                                                                                                                                                                          |
| 10.3          | Gerber Scientific, Inc. Agreement for Deferment of Director Fees, as amended (incorporated herein by reference to Exhibit 10.1 to Gerber's Current Report on Form 8-K filed on December 2, 2005).                                             |
|          |                                                                                                                                                                                                                                          |
| 10.4          | Gerber Scientific, Inc. 2006 Omnibus Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.1 to Gerber's Form 8-K filed on September 23, 2009).                                                                          |
|          |                                                                                                                                                                                                                                          |
| 10.5          | Form of Indemnification Agreement for Directors (incorporated herein by reference to Exhibit 10.1 to Gerber’s Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2009).                                                |
|          |                                                                                                                                                                                                                                          |
| 10.6          | Letter Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc. and Marc T. Giles (incorporated herein by reference to Exhibit 10.6 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2002). |

----

|   |                                                                                                                                                                                                                                                                                                               |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.7   | Letter Agreement, dated as of March 14, 2008, between Gerber Scientific, Inc. and Michael R. Elia (incorporated herein by reference to Exhibit 10.6 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2008).                                                                              |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.8   | Form of Restricted Stock Agreement under the Gerber Scientific, Inc. 2006 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 99.1 to Gerber's Current Report on Form 8-K filed on November 9, 2006).                                                                                              |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.9   | Form of Nonqualified Stock Option Agreement under the Gerber Scientific, Inc. 2006 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 99.2 to Gerber's Current Report on Form 8-K filed on November 9, 2006).                                                                                     |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.10  | Letter Agreement, dated as of September 30, 2002, between Gerber Scientific, Inc. and James S. Arthurs (incorporated herein by reference to Exhibit 10.15 of Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2003).                                                                        |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.11  | Letter Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc. and John R. Hancock (incorporated herein by reference to Exhibit 10.8 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2002).                                                                    |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.12  | Form of Change in Control Agreement, dated July 14, 1999, between Gerber Scientific, Inc. and its Senior Vice Presidents, including Marc T. Giles (incorporated herein by reference to Exhibit 10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 1999).                         |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.13  | Severance Policy for Senior Officers of Gerber Scientific, Inc. as Amended and Restated Effective September 21, 2006 (incorporated herein by reference to Exhibit 10.12 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2007).                                                          |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.14  | Agreement and Lease between Spandex PLC and IM Properties Finance Limited for the sale and leaseback of property in Bristol, United Kingdom (incorporated herein by reference to Exhibit 10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2001).                            |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.15  | Lease Agreement between GERB (CT) QRS 14-73, Inc. and Gerber Scientific, Inc., Gerber Technology, Inc., Gerber Scientific Products, Inc., and Gerber Coburn Optical, Inc. (incorporated herein by reference to Exhibit 10.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2001). |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.16  | Gerber Scientific, Inc. and Participating Subsidiaries Supplemental Pension Benefit Plan (incorporated herein by reference to Exhibit 10.5 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 1999).                                                                                       |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.17  | First Amendment to the Gerber Scientific, Inc. and Participating Subsidiaries Supplemental Pension Benefit Plan (incorporated herein by reference to Exhibit 10.28 to Gerber’s Annual Report on Form 10-K for the fiscal year ended April 30, 2009).                                                         |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.18  | Gerber Scientific, Inc. 1992 Employee Stock Plan, as amended and restated (incorporated herein by reference to Exhibit A to Gerber's Proxy Statement on Schedule 14A filed on August 28, 1995).                                                                                                                    |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.19  | Gerber Scientific, Inc. 2003 Employee Stock Option Plan, as amended and restated (incorporated herein by reference to Exhibit 10.17 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2007).                                                                                              |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.20  | Description of Arrangements Relating to Travel Compensation for Michael R. Elia and Thomas P. Finn.  Filed herewith.                                                                                                                                                                                     |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.21  | Letter Agreement, dated as of October 1, 2004, between Gerber Scientific, Inc. and William V. Grickis, Jr. (incorporated herein by reference to Exhibit 10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2004).                                                             |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.22  | Letter Agreement, dated as of December 18, 2003, between Gerber Scientific, Inc. and Donald P. Aiken (incorporated herein by reference to Exhibit 10.33 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2004).                                                                          |
|   |                                                                                                                                                                                                                                                                                                               |
| 10.23  | Form of Nonqualified Stock Option Agreement pursuant to the Gerber Scientific, Inc. 2003 Employee Stock Option Plan (incorporated herein by reference to Exhibit 10.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2004).                                                    |

----

|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.24  | Form of Restricted Stock Agreement pursuant to the Gerber Scientific, Inc. 2003 Employee Stock Option Plan (incorporated herein by reference to Exhibit 10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2004).                                                                                                                                                                                                                                                                        |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.25  | Change in Control Agreement, dated October 1, 2005, between Gerber Scientific, Inc. and William V. Grickis, Jr. (incorporated herein by reference to Exhibit 10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2004).                                                                                                                                                                                                                                                                   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.26  | Change in Control Agreement, dated April 15, 2008, between Gerber Scientific, Inc. and Michael R. Elia (incorporated herein by reference to Exhibit 10.24 to Gerber's Annual Report on Form 10-K for the fiscal year ended April 30, 2008).                                                                                                                                                                                                                                                                                   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.27  | Credit Agreement, dated as of January 31, 2008, among Gerber Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch Capital Corporation, Bank of America, N.A., Sovereign Bank as documentation agent, Citizens Bank of Massachusetts as administrative agent, and RBS Greenwich Capital as sole lead arranger (incorporated herein by reference to Exhibit 10.1 to Gerber's Current Report on Form 8-K filed on February 6, 2008). |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.28  | First Amendment to Credit Agreement, dated as of November 21, 2008, among Gerber Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS Citizens N.A. as lender and agent (incorporated herein by reference to Exhibit 10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2008).                                           |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.29  | Second Amendment to Credit Agreement, dated as of March 4, 2009, among Gerber Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS Citizens N.A. as lender and agent (incorporated herein by reference to Exhibit 10.28 to Gerber’s Annual Report on Form 10-K for the fiscal year ended April 30, 2009).                                               |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.29  | Third Amendment to Credit Agreement, dated as of November 19, 2009, among Gerber Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS Citizens N.A. as lender and agent (incorporated by reference to Exhibit 10.1 to Gerber’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2010).                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.30  | Change in Control Agreement, dated February 16, 2010, between Gerber Scientific, Inc. and Thomas P. Finn.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.31  | Letter agreement, dated as of January 22, 2010, between Gerber Scientific, Inc. and Thomas P. Finn.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.32  | Summary of Terms of Retention Plan for Stephen Lovass.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 21.1   | Subsidiaries of Gerber.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 23.1   | Consent of Independent Registered Public Accounting Firm.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 31.1   | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 31.2   | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                                   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 32     | Certification of Chief Executive Officer and Chief Financial Officer pursuant Rule 13a-14(b) or Rule 15d-14(b) and to 18 U.S.C. §1350.  Filed herewith.                                                                                                                                                                                                                                                                                                                                                        |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| (b)    | See Item 15(a) 3. above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| (c)    | See Item 15(a) 2. above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

----

Management's Report on Internal Control over Financial Reporting

----

 Report of Independent Registered Public Accounting Firm

----

Consolidated Statements of Operations

|                                                                                     | For the Fiscal Years Ended April 30,      |
|------------------------------------------------------------------------------------------|---------------------------------------------------------------|
| In thousands of dollars, except per share data                                           |                                                          | 2010 |   |   | 2009 |   |   | 2008 |   |
| Revenue:                                                                                 |                                                          |   |   |   |   |   |   |   |   |
| Product sales                                                                            |                                                          | $ | 393,439 |   |   | $ | 427,783 |   |   | $ | 520,894 |   |
| Service sales                                                                            |                                                          |   | 64,916 |   |   |   | 71,157 |   |   |   | 73,404 |   |
|                                                                                     |                                                          |   | 458,355 |   |   |   | 498,940 |   |   |   | 594,298 |   |
| Cost of Sales:                                                                           |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Cost of products sold                                                                    |                                                          |   | 283,257 |   |   |   | 310,295 |   |   |   | 367,157 |   |
| Cost of services sold                                                                    |                                                          |   | 40,465 |   |   |   | 45,030 |   |   |   | 48,361 |   |
|                                                                                     |                                                          |   | 323,722 |   |   |   | 355,325 |   |   |   | 415,518 |   |
|                                                                                     |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Gross profit                                                                             |                                                          |   | 134,633 |   |   |   | 143,615 |   |   |   | 178,780 |   |
|                                                                                     |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Selling, general and administrative expenses                                             |                                                          |   | 106,062 |   |   |   | 114,607 |   |   |   | 127,555 |   |
| Research and development                                                                 |                                                          |   | 18,517 |   |   |   | 21,123 |   |   |   | 26,187 |   |
| Restructuring and other expenses                                                         |                                                          |   | 2,654 |   |   |   | 1,168 |   |   |   | 250 |   |
| Operating income                                                                         |                                                          |   | 7,400 |   |   |   | 6,717 |   |   |   | 24,788 |   |
|                                                                                     |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Other income (expense), net                                                              |                                                          |   | (1,366 | ) |   |   | (2,804 | ) |   |   | 264 |   |
| Interest expense                                                                         |                                                          |   | (4,160 | ) |   |   | (3,133 | ) |   |   | (3,895 | ) |
| Income from continuing operations before income taxes                                    |                                                          |   | 1,874 |   |   |   | 780 |   |   |   | 21,157 |   |
| Income tax expense (benefit)                                                             |                                                          |   | 532 |   |   |   | (4,021 | ) |   |   | 6,043 |   |
| Income from continuing operations, net of taxes                                          |                                                          |   | 1,342 |   |   |   | 4,801 |   |   |   | 15,114 |   |
| Loss from discontinued operations, net of taxes of $(1,156), $84, and $205, respectively |                                                          |   | (2,800 | ) |   |   | (2,565 | ) |   |   | (610 | ) |
| Net (loss) income                                                                        |                                                          | $ | (1,458 | ) |   | $ | 2,236 |   |   | $ | 14,504 |   |
| Basic (Loss) Earnings Per Share of Common Stock:                                         |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                                    |                                                          | $ | 0.05 |   |   | $ | 0.20 |   |   | $ | 0.64 |   |
| Discontinued operations                                                                  |                                                          |   | (0.11 | ) |   |   | (0.11 | ) |   |   | (0.02 | ) |
| Basic (loss) earnings per common share                                                   |                                                          | $ | (0.06 | ) |   | $ | 0.09 |   |   | $ | 0.62 |   |
| Diluted (Loss) Earnings Per Share of Common Stock:                                       |                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                                    |                                                          | $ | 0.05 |   |   | $ | 0.20 |   |   | $ | 0.64 |   |
| Discontinued operations                                                                  |                                                          |   | (0.11 | ) |   |   | (0.11 | ) |   |   | (0.03 | ) |
| Diluted (loss) earnings per common share                                                 |                                                          | $ | (0.06 | ) |   | $ | 0.09 |   |   | $ | 0.61 |   |

----

Consolidated Balance Sheets

|                                                                                           |   | April 30, |    |
|------------------------------------------------------------------------------------------------|--------|-----------|---------|
| In thousands of dollars and shares                                                             |   | 2010      |    |   | 2009 |   |
| Assets:                                                                                        |   |      |    |   |   |   |
| Current Assets:                                                                                |   |      |    |   |   |   |
| Cash and cash equivalents                                                                      |   | $         | 11,305  |   |   | $ | 10,313 |   |
| Accounts receivable (net of allowance for doubtful accounts of $7,756 and $6,741)              |   |      | 80,925  |   |   |   | 87,798 |   |
| Inventories                                                                                    |   |      | 59,823  |   |   |   | 72,108 |   |
| Deferred tax assets, net                                                                       |   |      | 10,029  |   |   |   | 9,022 |   |
| Prepaid expenses and other current assets                                                      |   |      | 4,732   |   |   |   | 4,659 |   |
| Total Current Assets                                                                           |   |      | 166,814 |   |   |   | 183,900 |   |
| Property, plant and equipment, net                                                             |   |      | 32,223  |   |   |   | 37,119 |   |
| Goodwill                                                                                       |   |      | 83,654  |   |   |   | 76,940 |   |
| Deferred tax assets, net                                                                       |   |      | 48,362  |   |   |   | 43,339 |   |
| Other assets                                                                                   |   |      | 20,824  |   |   |   | 17,919 |   |
| Total Assets                                                                                   |   | $         | 351,877 |   |   | $ | 359,217 |   |
| Liabilities and Shareholders' Equity:                                                          |   |      |    |   |   |   |   |   |
| Current Liabilities:                                                                           |   |      |    |   |   |   |   |   |
| Accounts payable                                                                               |   |  $   | 39,185  |   |   | $  | 37,494 |   |
| Accrued compensation and benefits                                                              |   |      | 15,997  |   |   |   | 15,735 |   |
| Other accrued liabilities                                                                      |   |      | 22,080  |   |   |   | 24,748 |   |
| Deferred revenue                                                                               |   |      | 13,003  |   |   |   | 13,084 |   |
| Total Current Liabilities                                                                      |   |      | 90,265  |   |   |   | 91,061 |   |
| Long-term debt                                                                                 |   |      | 45,000  |   |   |   | 73,500 |   |
| Accrued pension benefit liability                                                              |   |      | 36,932  |   |   |   | 29,629 |   |
| Other long-term liabilities                                                                    |   |      | 8,874   |   |   |   | 6,019 |   |
| Deferred tax liabilities, net                                                                  |   |      | 12,600  |   |   |   | 10,706 |   |
|                                                                                           |   |      |    |   |   |   |   |   |
| Commitments and contingencies (Note 18)                                                        |   |      |    |   |   |   |   |   |
|  Shareholders' Equity:                                                                    |   |      |    |   |   |   |   |   |
| Preferred stock, $0.01 par value; authorized 10,000 shares; no shares issued                   |   |      | ---     |   |   |   | --- |   |
| Common stock, $0.01 par value; authorized 100,000 shares; issued 25,650 and 25,174 shares |   |      | 257     |   |   |   | 252 |   |
| Paid-in capital                                                                                |   |      | 81,981  |   |   |   | 79,198 |   |
| Retained earnings                                                                              |   |      | 96,204  |   |   |   | 97,662 |   |
| Treasury stock, 528 and 561 shares, at cost                                                    |   |      | (10,855 | ) |   |   | (11,531 | ) |
| Accumulated other comprehensive loss                                                           |   |      | (9,381  | ) |   |   | (17,279 | ) |
| Total Shareholders' Equity                                                                     |   |      | 158,206 |   |   |   | 148,302 |   |
| Total Liabilities and Shareholders' Equity                                                     |   | $         | 351,877 |   |   | $ | 359,217 |   |

----

Consolidated Statements of Cash Flows

|                                                                                 | For the Fiscal Years Ended April 30, |   |
|--------------------------------------------------------------------------------------|--------------------------------------|--------|
| In thousands of dollars                                                              |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Cash flows from operating activities:                                                |                                 |   |   |   |   |   |   |   |   |
| Net (loss) income                                                                    |                                 | $      | (1,458 | ) |   | $ | 2,236 |   |   | $ | 14,504 |   |
| Adjustments to reconcile net (loss) income to cash provided by operating activities: |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Depreciation and amortization                                                        |                                 |   | 9,452 |   |   |   | 9,991 |   |   |   | 9,518 |   |
| Deferred income taxes                                                                |                                 |   | (3,210 | ) |   |   | (5,953 | ) |   |   | 2,501 |   |
| Other-than-temporary impairment charge                                               |                                 |   | --- |   |   |   | 2,290 |   |   |   | --- |   |
| Stock-based compensation                                                             |                                 |   | 3,787 |   |   |   | 3,241 |   |   |   | 1,805 |   |
| Loss (Gain) on sale of assets                                                        |                                 |   | 2,464 |   |   |   | (622 | ) |   |   | (2,287 | ) |
| Other noncash items                                                                  |                                 |   | 2,177 |   |   |   | 2,220 |   |   |   | 2,191 |   |
| Changes in operating accounts, excluding effects of acquisitions:                    |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Accounts receivable                                                                  |                                 |   | 5,126 |   |   |   | 25,795 |   |   |   | (5,719 | ) |
| Inventories                                                                          |                                 |   | 5,996 |   |   |   | 5,820 |   |   |   | (6,220 | ) |
| Prepaid expenses and other assets                                                    |                                 |   | 71 |   |   |   | 79 |   |   |   | 696 |   |
| Accounts payable and other accrued liabilities                                       |                                 |   | 706 |   |   |   | (27,424 | ) |   |   | (7,095 | ) |
| Accrued compensation and benefits                                                    |                                 |   | (15 | ) |   |   | (7,899 | ) |   |   | 311 |   |
| Net cash provided by operating activities                                            |                                 |   | 25,096 |   |   |   | 9,774 |   |   |   | 10,205 |   |
| Cash flows from investing activities:                                                |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Capital expenditures                                                                 |                                 |   | (4,489 | ) |   |   | (8,187 | ) |   |   | (8,589 | ) |
| Proceeds from sale of available for sale investments                                 |                                 |   | 464 |   |   |   | 705 |   |   |   | 751 |   |
| Purchases of available for sale investments                                          |                                 |   | (308 | ) |   |   | (457 | ) |   |   | (753 | ) |
| Proceeds from sale of net assets                                                     |                                 |   | 13,709 |   |   |   | 2,622 |   |   |   | 345 |   |
| Business acquisitions                                                                |                                 |   | (3,473 | ) |   |   | (34,273 | ) |   |   | (4,650 | ) |
| Investments in intangible assets                                                     |                                 |   | (1,368 | ) |   |   | (828 | ) |   |   | (868 | ) |
| Net cash provided by (used for) investing activities                                 |                                 |   | 4,535 |   |   |   | (40,418 | ) |   |   | (13,764 | ) |
| Cash flows from financing activities:                                                |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Debt repayments                                                                      |                                 |   | (117,176 | ) |   |   | (80,271 | ) |   |   | (314,256 | ) |
| Debt proceeds                                                                        |                                 |   | 89,525 |   |   |   | 110,686 |   |   |   | 321,862 |   |
| Debt issuance costs                                                                  |                                 |   | (494 | ) |   |   | (1,174 | ) |   |   | (993 | ) |
| Common stock activities                                                              |                                 |   | (486 | ) |   |   | 898 |   |   |   | 1,373 |   |
| Other financing activities                                                           |                                 |   | (341 | ) |   |   | --- |   |   |   | --- |   |
| Net cash (used for) provided by financing activities                                 |                                 |   | (28,972 | ) |   |   | 30,139 |   |   |   | 7,986 |   |
| Effect of exchange rate changes on cash                                              |                                 |   | 333 |   |   |   | (3,074 | ) |   |   | 1,413 |   |
| Increase (Decrease) in cash and cash equivalents                                     |                                 |   | 992 |   |   |   | (3,579 | ) |   |   | 5,840 |   |
| Cash and cash equivalents at beginning of year                                       |                                 |   | 10,313 |   |   |   | 13,892 |   |   |   | 8,052 |   |
| Cash and cash equivalents at end of year                                             |                                 | $      | 11,305 |   |   | $ | 10,313 |   |   | $ | 13,892 |   |
|                                                                                 |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental Schedule of Cash Flow Information                                       |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Cash paid during the year for:                                                       |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Interest                                                                             |                                 | $      | 3,475 |   |   | $ | 2,856 |   |   | $ | 3,655 |   |
| Income taxes, net of refunds                                                         |                                 | $      | 4,517 |   |   | $ | 4,456 |   |   | $ | 5,290 |   |

----

Consolidated Statements of Changes in Shareholders' Equity

| In thousands of dollars and shares                                                                                             | IssuedCommonStockShares |   | CommonStock | Paid-inCapital |   | RetainedEarnings |   | TreasuryStock |   |   | Accum.OtherComp.Income(Loss) |   | Total  |    |   |
|--------------------------------------------------------------------------------------------------------------------------------|-------------------------|--------|-------------|----------------|--------|------------------|--------|---------------|--------|--------|------------------------------|--------|--------|---------|--------|
| Balance as of April 30, 2007                                                                                                   | 23,809                  |   |        | $              | 238    |             |   | $             | 72,612 |   |                         | $      | 83,290 |    | $      | (12,814 | ) |   |   | $ | 1,155 |   |   | $ | 144,481 |   |
| Net income                                                                                                                     | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | 14,504 |    |   | -- |   |   |   |   | -- |   |   |   | 14,504 |   |
| Currency translation adjustments                                                                                               | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | 11,686 |   |   |   | 11,686 |   |
| Unrealized loss on securities, net of reclassification adjustment of $26 and    tax of $(289)              | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (486 | ) |   |   | (486 | ) |
| Change in pension plans, net of tax of $1,059                                                                                  | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (1,785 | ) |   |   | (1,785 | ) |
| Comprehensive income                                                                                                           |                    |   |        |           |   |             |   |          |   |   |                         |   |   |    |   |   |   |   |   |   |   |   |   |   | 23,919 |   |
| Cumulative effect of adoption for accounting for uncertainty in income taxes                                                   | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | (2,368 | )       |   | -- |   |   |   |   | -- |   |   |   | (2,368 | ) |
| Stock issued to Directors                                                                                                      | --                      |   |        |           | --     |             |   |          | (323   | )      |                         |   | --     |    |   | 666 |   |   |   |   | -- |   |   |   | 343 |   |
| Stock issued under employee plans, net                                                                                         | 216                     |   |        |           | 2      |             |   |          | 1,381  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 1,383 |   |
| Stock based compensation expense                                                                                               | --                      |   |        |           | --     |             |   |          | 1,408  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 1,408 |   |
| Restricted stock grants and cancellations, net of amortization                                                                 | 275                     |   |        |           | 3      |             |   |          | 394    |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 397 |   |
| Balance as of April 30, 2008                                                                                                   | 24,300                  |   |        | $              | 243    |             |   | $             | 75,472 |   |                         | $      | 95,426 |    | $      | (12,148 | ) |   |   | $ | 10,570 |   |   | $ | 169,563 |   |
| Net income                                                                                                                     | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | 2,236  |    |   | -- |   |   |   |   | -- |   |   |   | 2,236 |   |
| Currency translation adjustments                                                                                               | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (25,709 | ) |   |   | (25,709 | ) |
| Unrealized gain on securities, net of reclassification adjustment of $2,423 and      tax of $341 | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | 574 |   |   |   | 574 |   |
| Change in pension plans, net of tax of $1,172                                                                                  | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (1,973 | ) |   |   | (1,973 | ) |
| Change in derivative instruments, net of    tax of $440                                                    | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (741 | ) |   |   | (741 | ) |
| Comprehensive loss                                                                                                             |                    |   |        |           |   |             |   |          |   |   |                         |   |   |    |   |   |   |   |   |   |   |   |   |   | (25,613 | ) |
| Stock issued to Directors                                                                                                      | --                      |   |        |           | --     |             |   |          | (407   | )      |                         |   | --     |    |   | 617 |   |   |   |   | -- |   |   |   | 210 |   |
| Stock issued under employee plans, net                                                                                         | 131                     |   |        |           | 1      |             |   |          | 900    |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 901 |   |
| Stock based compensation expense                                                                                               | --                      |   |        |           | --     |             |   |          | 2,032  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 2,032 |   |
| Restricted stock grants and cancellations, net of amortization                                                                 | 743                     |   |        |           | 8      |             |   |          | 1,201  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 1,209 |   |
| Balance as of April 30, 2009                                                                                                   | 25,174                  |   |        | $              | 252    |             |   | $             | 79,198 |   |                         | $      | 97,662 |    | $      | (11,531 | ) |   |   | $ | (17,279 | ) |   | $ | 148,302 |   |
| Net loss                                                                                                                       | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | (1,458 | )  |   | -- |   |   |   |   | -- |   |   |   | (1,458 | )  |
| Currency translation adjustments                                                                                               | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | 10,453 |   |   |   | 10,453 |   |
| Unrealized gain on securities, net of reclassification adjustment of $64 and    tax of $350                | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | 590 |   |   |   | 590 |   |
| Change in pension plans, net of tax of $(2,128)                                                                                | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | (3,585 | ) |   |   | (3,585 | ) |
| Change in derivative instruments, net of    tax of $262                                                    | --                      |   |        |           | --     |             |   |          | --     |   |                         |   | --     |    |   | -- |   |   |   |   | 440 |   |   |   | 440 |   |
| Comprehensive income                                                                                                           |                    |   |        |           |   |             |   |          |   |   |                         |   |   |    |   |   |   |   |   |   |   |   |   |   | 6,440 |   |
| Stock issued to Directors                                                                                                      | --                      |   |        |           | --     |             |   |          | (512   | )      |                         |   | --     |    |   | 676 |   |   |   |   | -- |   |   |   | 164 |   |
| Shares withheld for employee taxes, net                                                                                        | (74                     | )      |        |           | (1     | )                |   |          | (485   | )      |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | (486 | ) |
| Stock based compensation expense                                                                                               | --                      |   |        |           | --     |             |   |          | 1,557  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 1,557 |   |
| Restricted stock grants and cancellations, net of amortization                                                                 | 550                     |   |        |           | 6      |             |   |          | 2,223  |   |                         |   | --     |    |   | -- |   |   |   |   | -- |   |   |   | 2,229 |   |
| Balance as of April 30, 2010                                                                                                   | 25,650                  |   |        | $              | 257    |             |   | $             | 81,981 |   |                         | $      | 96,204 |    | $      | (10,855 | ) |   |   | $ | (9,381 | ) |   | $ | 158,206 |   |

----

Notes to Consolidated Financial Statements

----

----

| ·   | persuasive evidence of an arrangement exists; |
|--------------------|-----------------------------------------------|

| ·   | delivery has occurred or services have been rendered; |
|--------------------|-------------------------------------------------------|

| ·   | the price is fixed or determinable; and |
|--------------------|-----------------------------------------|

| ·   | collectability is reasonably assured. |
|--------------------|---------------------------------------|

----

| ·   | The equipment the Company sells has value on a stand-alone basis. The Company's customers may resell equipment on a stand-alone basis and there is an observable market for the equipment.  The Company also may sell the equipment without installation, training or service agreements. In these cases, the overall sales price is reduced by an amount equal to the fair value of any undelivered elements, as applicable. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | There is objective and reliable evidence of the fair value of the undelivered items, as applicable. The Company calculates the fair value of these elements based on the same, or similar, services provided to customers on a stand-alone basis. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | There are no general rights of return relating to the equipment.  The Company has no obligation to accept the return of products sold other than for repair or replacement of defective products, which must be authorized in advance. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| In thousands | Balance atBeginning ofFiscal Year |   | Charges toCosts andExpenses1 |   |   Deductions2 |     |     | Impact of Business Dispositions | Balance atEnd ofFiscal Year |   |
|--------------|-----------------------------------|--------|------------------------------|--------|--------------------|--------------------|--------------------|---------------------------------|-----------------------------|--------|
| Fiscal 2010  |                              | $      | 6,741                        |   |               | $                  | 4,305              |                            |                        | $      | (3,233 | ) |   | $ |  (57 | ) |   | $ | 7,756 |   |
| Fiscal 2009  |                              | $      | 6,384                        |   |               | $                  | 2,733              |                            |                        | $      | (2,376 | ) |   | $ | --- |   |   | $ | 6,741 |   |
| Fiscal 2008  |                              | $      | 7,012                        |   |               | $                  | 2,524              |                            |                        | $      | (3,152 | ) |   | $ | --- |   |   | $ | 6,384 |   |

|   | 2 Deductions include accounts receivable written off and recoveries. |
|--------|----------------------------------------------------------------------|

|                              |   | April 30, |   |
|-----------------------------------|--------|-----------|--------|
| In thousands                      |   | 2010      |   |   | 2009 |   |
| Raw materials and purchased parts |   | $         | 49,400 |   |   | $ | 58,779 |   |
| Work in process                   |   |      | 1,774  |   |   |   | 3,510 |   |
| Finished goods                    |   |      | 8,649  |   |   |   | 9,819 |   |
| Total inventories                 |   | $         | 59,823 |   |   | $ | 72,108 |   |

|                                     |   | April 30, |    |
|------------------------------------------|--------|-----------|---------|
| In thousands                             |   | 2010      |    |   | 2009 |   |
| Land                                     |   | $         | 1,036   |   |   | $ | 1,020 |   |
| Buildings                                |   |      | 33,128  |   |   |   | 35,166 |   |
| Machinery, tools and equipment           |   |      | 84,908  |   |   |   | 96,457 |   |
|                                     |   |      | 119,072 |   |   |   | 132,643 |   |
| Accumulated depreciation                 |   |      | (90,454 | ) |   |   | (101,091 | ) |
|                                     |   |      | 28,618  |   |   |   | 31,552 |   |
| Construction in progress                 |   |      | 3,605   |   |   |   | 5,567 |   |
| Total property, plant and equipment, net |   | $         | 32,223  |   |   | $ | 37,119 |   |

----

|  In thousands                                           |   | November 25, 2009 |   |
|--------------------------------------------------------------|--------|-------------------|--------|
| Assets acquired:                                             |   |              |   |
| Accounts receivable                                          |   | $                 | 194    |   |
| Prepaid expenses and other current assets                    |   |              | 12     |   |
| Goodwill                                                     |   |              | 3,653  |   |
| Other assets                                                 |   |              | 2,796  |   |
|      Total assets acquired          |   | $                 | 6,655  |   |
| Liabilities assumed:                                         |   |              |   |   |
| Accounts payable                                             |   |              | 33     |   |
| Other accrued liabilities                                    |   |              | 158    |   |
| Deferred revenue                                             |   |              | 257    |   |
| Other long-term liabilities                                  |   |              | 1,021  |   |
|      Total liabilities assumed      |   | $                 | 1,469  |   |
| Net assets acquired                                          |   | $                 | 5,186  |   |
| Consideration:                                               |   |              |   |   |
|   Cash payment                                     |   | $                 | 2,012  |   |
|   Estimated fair value of contingent consideration |   |              | 3,174  |   |
| Total consideration                                          |   | $                 | 5,186  |   |

----

|  In thousands                                      |   | October 21, 2008 |   |
|---------------------------------------------------------|--------|------------------|--------|
| Assets acquired:                                        |   |             |   |
| Cash and cash equivalents                               |   | $                | 4,128  |   |
| Accounts receivable                                     |   |             | 6,940  |   |
| Inventories                                             |   |             | 8,756  |   |
| Prepaid and other assets                                |   |             | 615    |   |
| Property, plant and equipment                           |   |             | 1,831  |   |
| Goodwill                                                |   |             | 15,968 |   |
| Deferred tax assets                                     |   |             | 3,030  |   |
| Other assets                                            |   |             | 3,135  |   |
|      Total assets acquired     |   | $                | 44,403 |   |
| Liabilities assumed:                                    |   |             |   |   |
| Accounts payable                                        |   | $                | 2,499  |   |
| Accrued compensation and benefits                       |   |             | 2,893  |   |
| Other liabilities                                       |   |             | 5,599  |   |
| Deferred revenue                                        |   |             | 959    |   |
|      Total liabilities assumed |   | $                | 11,950 |   |
| Net assets acquired                                     |   | $                | 32,453 |   |

----

| In thousands                                      | May 1, 2007 |   |
|---------------------------------------------------|-------------|--------|
| Assets acquired:                                  |        |   |   |
| Cash and cash equivalents                         |        | $      | 500 |   |
| Accounts receivable                               |        |   | 701 |   |
| Inventories                                       |        |   | 2,106 |   |
| Prepaid expenses and other current assets         |        |   | 71 |   |
| Property, plant and equipment                     |        |   | 450 |   |
| Goodwill                                          |        |   | 5,954 |   |
| Other assets                                      |        |   | 68 |   |
|     Total assets acquired     |        | $      | 9,850 |   |
| Liabilities assumed:                              |        |   |   |   |
| Accounts payable                                  |        | $      | 1,447 |   |
| Accrued compensation and benefits                 |        |   | 139 |   |
| Other accrued liabilities                         |        |   | 841 |   |
| Deferred revenue                                  |        |   | 1,038 |   |
| Deferred income taxes                             |        |   | 223 |   |
| Long-term debt                                    |        |   | 1,012 |   |
|     Total liabilities assumed |        | $      | 4,700 |   |
| Net assets acquired                               |        | $      | 5,150 |   |

|                              |   | April 30, 2010      |   |                           | April 30, 2009 |   |
|-----------------------------------|--------|---------------------|--------|--------------------------------|----------------|--------|
| In thousands                      |   | GrossCarryingAmount |   |   AccumulatedAmortization |           |   | Gross Carrying Amount |   |   AccumulatedAmortization |   |
| Amortized intangible assets:      |   |                |   |                           |           |   |   |   |   |   |   |   |
| Patents                           |   | $                   | 7,732  |                           |           | $      | 3,641 |   |   | $ | 7,603 |   |   | $ | 3,210 |   |
| Other                             |   |                | 8,346  |                           |           |   | 1,136 |   |   |   | 5,131 |   |   |   | 739 |   |
| Total amortized intangible assets |   | $                   | 16,078 |                           |           | $      | 4,777 |   |   | $ | 12,734 |   |   | $ | 3,949 |   |

----

| In thousands                                        | Sign Making& SpecialtyGraphics |   | Apparel &Industrial |   | OphthalmicLensProcessing |   |   | Total  |   |
|-----------------------------------------------------|------------------------------------|--------|-------------------------|--------|--------------------------|--------|--------|--------|--------|
| Balance as of April 30, 2008                        |                               |   |                    |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Gross goodwill                                      |                               | $      | 123,652                 |   |                     | $      | 14,149 |   |   | $ | 38,696 |   |   | $ | 176,497 |   |
| Accumulated impairment losses                       |                               |   | (92,953                 | )      |                     |   | ---    |   |   |   | (21,700 | ) |   |   | (114,653 | ) |
| Net balance as of April 30, 2008                    |                               | $      | 30,699                  |   |                     | $      | 14,149 |   |   | $ | 16,996 |   |   | $ | 61,844 |   |
| Goodwill acquired during the year from acquisitions |                               |   | ---                     |   |                     |   | 20,245 |   |   |   | --- |   |   |   | 20,245 |   |
| Adjustment to previously reported goodwill          |                               |   | 92                      |   |                     |   | ---    |   |   |   | --- |   |   |   | 92 |   |
| Effects of currency translation                     |                               |   | (5,054                  | )      |                     |   | (187   | )      |   |   | --- |   |   |   | (5,241 | ) |
| Net balance as of April 30, 2009                    |                               | $      | 25,737                  |   |                     | $      | 34,207 |   |   | $ | 16,996 |   |   | $ | 76,940 |   |
| Goodwill acquired during the year from acquisitions |                               |   | 1,086                   |   |                     |   | 4,021  |   |   |   | --- |   |   |   | 5,107 |   |
| Goodwill related to the sale of a business          |                               |   | (1,009                  | )      |                     |   | (1,581 | )      |   |   | (108 | ) |   |   | (2,698 | ) |
| Effects of currency translation                     |                               |   | 1,541                   |   |                     |   | 2,764  |   |   |   | --- |   |   |   | 4,305 |   |
| Net balance as of April 30, 2010                    |                               | $      | 27,355                  |   |                     | $      | 39,411 |   |   | $ | 16,888 |   |   | $ | 83,654 |   |
| Net balance as of April 30, 2010 was comprised of:  |                               |   |                    |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Gross goodwill                                      |                               |   | 120,308                 |   |                     |   | 39,411 |   |   |   | 38,588 |   |   |   | 198,307 |   |
| Accumulated impairment losses                       |                               |   | (92,953                 | )      |                     |   | ---    |   |   |   | (21,700 | ) |   |   | (114,653 | ) |
| Net balance as of April 30, 2010                    |                               | $      | 27,355                  |   |                     | $      | 39,411 |   |   | $ | 16,888 |   |   | $ | 83,654 |   |

|         |   | For the Fiscal Years Ended April 30, |   |
|--------------|--------|--------------------------------------|--------|
|         |   | 2010                                 |   |   | 2009 |   |
| In thousands |   | Cost                                 |   | Unrealized Gains |   | Estimated Fair Value |   |   | Cost |   |   | UnrealizedGains |   |   | Estimated Fair Value |   |
| Mutual fund  |   | $                                    | 2,707  |   |   | $ | 1,099 |   |   | $ | 3,806  |   |   | $ | 2,796 |   |   | $ | 159 |   |   | $ | 2,955  |   |

----

|                         |   | For the Fiscal Years Ended April 30, |   |
|------------------------------|--------|--------------------------------------|--------|
| In thousands                 |   | 2010                                 |   |   | 2009 |   |   | 2008 |   |
| Current:                     |   |                                 |   |   |   |   |   |   |   |
| Federal                      |   | $                                    | (83    | ) |   | $ | (270 | ) |   | $ | (1,602 | ) |
| State and local              |   |                                 | 85     |   |   |   |  95 |   |   |   | 273 |   |
| Foreign                      |   |                                 | 3,499  |   |   |   | 1,895 |   |   |   | 6,201 |   |
| Total current                |   |                                 | 3,501  |   |   |   | 1,720 |   |   |   | 4,872 |   |
| Deferred:                    |   |                                 |   |   |   |   |   |   |   |   |   |   |
| Federal                      |   |                                 | (4,312 | ) |   |   | (3,134 | ) |   |   | 900 |   |
| State and local              |   |                                 | (194   | ) |   |   | (106 | ) |   |   | 128 |   |
| Foreign                      |   |                                 | 1,537  |   |   |   | (2,501 | ) |   |   | 143 |   |
| Total deferred               |   |                                 | (2,969 | ) |   |   | (5,741 | ) |   |   | 1,171 |   |
| Income tax expense (benefit) |   | $                                    | 532    |   |   | $ | (4,021 | ) |   | $ | 6,043 |   |

|                                                              | For the Fiscal Years Ended April 30, |   |
|-------------------------------------------------------------------|--------------------------------------|--------|
|                                                              |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Statutory U.S. federal income tax rate                            |                                 |   | 35.0 | % |   |   | 35.0 |  % |   |   | 35.0 | % |
| State income taxes, net of US federal tax benefit                 |                                 |   | (7.4 | )  |   |   | 8.1 |   |   |   | 1.2 |   |
| Reversal of valuation allowance in France                         |                                 |   | --- |   |   |   | (415.8 | )  |   |   | --- |   |
| Foreign tax differences and other valuation allowance adjustments |                                 |   | (50.7 | )  |   |   | (23.8 | )  |   |   | (4.6 | )  |
| Impact of repatriation of foreign earnings                        |                                 |   | (25.8 | ) |   |   | 31.7 |   |   |   | 4.0 |   |
| Belgian notional interest deduction                               |                                 |   | (14.2 | ) |   |   | (43.5 | ) |   |   | --- |   |
| Research and development tax credits                              |                                 |   | (13.2 | )  |   |   | (45.5 | )  |   |   | (1.9 | )  |
| Prior years’ adjustments                                    |                                 |   | 75.2 |   |   |   | (74.2 | )  |   |   | (6.8 | )  |
| Nondeductible cost of acquisitions                                |                                 |   | 10.4 |   |   |   | --- |   |   |   | --- |   |
| Equity based compensation adjustments                             |                                 |   | 8.6 |   |   |   | 18.8 |   |   |   | --- |   |
| Other foreign taxes                                               |                                 |   | 7.0 |   |   |   | 9.5 |   |   |   | 0.9 |   |
| Other, net                                                        |                                 |   | 3.5 |   |   |   | (15.8 | )  |   |   | 0.8 |   |
| Effective income tax rate                                         |                                 |   | 28.4 | % |   |   | (515.5 | )% |   |   | 28.6 | % |

----

|                              | April 30, 2010     |    | April 30, 2009          |   |
|-----------------------------------|--------------------|---------|-------------------------|--------|
| In thousands                      | DeferredTax Assets |    | Deferred TaxLiabilities |   | DeferredTax Assets |   | Deferred TaxLiabilities |   |
| Depreciation                      | $                  | 1,022   |                    |   | $ | 1,599 |   | $ | 1,159 |   |   | $ | 1,265 |   |
| Patents                           |               | ---     |                    |   |   | 1,471 |   |   | --- |   |   |   | 1,519 |   |
| Employee benefit plans            |               | 14,765  |                    |   |   | 565 |   |   | 12,097 |   |   |   | 154 |   |
| Inventory                         |               | 6,254   |                    |   |   | 145 |   |   | 5,610 |   |   |   | --- |   |
| Asset valuations                  |               | 13,921  |                    |   |   | 7,733 |   |   | 13,691 |   |   |   | 6,799 |   |
| Provisions for estimated expenses |               | 4,435   |                    |   |   | --- |   |   | 3,417 |   |   |   | --- |   |
| Net operating losses              |               | 19,075  |                    |   |   | --- |   |   | 20,630 |   |   |   | --- |   |
| Credit carryforwards              |               | 10,491  |                    |   |   | 270 |   |   | 7,133 |   |   |   | 270 |   |
| Other                             |               | 4,455   |                    |   |   | 1,134 |   |   | 1,804 |   |   |   | 805 |   |
|                              |               | 74,418  |                    |   |   | 12,917 |   |   | 65,541 |   |   |   | 10,812 |   |
| Valuation allowance               |               | (17,118 | )                       |   |   | --- |   |   | (14,182 | ) |   |   | --- |   |
|                              | $                  | 57,300  |                    |   | $ | 12,917 |   | $ | 51,359 |   |   | $ | 10,812 |   |

|                                                  | For the Fiscal Years Ended April 30, |    |
|-------------------------------------------------------|--------------------------------------|---------|
| In thousands                                          | 2010                                 |    |   | 2009 |   |   | 2008 |   |
| United States                                         | $                                    | (14,680 | ) |   | $ | (11,963 | ) |   | $ | 439 |   |
| Foreign                                               |                                 | 16,554  |   |   |   | 12,743 |   |   |   | 20,718 |   |
| Income from continuing operations before income taxes | $                                    | 1,874   |   |   | $ | 780 |   |   | $ | 21,157 |   |

----

| In thousands | Balance atBeginning ofFiscal Year | Charges to Income Tax Expense |   | Acquired ValuationAllowances |   |   Deductions | 1     | Balance atEnd ofFiscal Year |   |
|--------------|-----------------------------------|-----------------------------------------|--------|------------------------------|--------|-------------------|-------|-----------------------------|--------|
| Fiscal 2010  |                              | $                                       | 14,182 |                         |   | $                 | 3,573 |                        |   | $ | --- |   |   | $ | (637 | ) |   | $ | 17,118 |   |
| Fiscal 2009  |                              | $                                       | 15,182 |                         |   | $                 | 1,142 |                        |   | $ | 1,176 |   |   | $ | (3,318 | ) |   | $ | 14,182 |   |
| Fiscal 2008  |                              | $                                       | 14,427 |                         |   | $                 | 842   |                        |   | $ | --- |   |   | $ | (87 | ) |   | $ | 15,182 |   |

| In thousands                                              |   | 2010   |   |   | 2009   |   |   | 2008   |   |
|-----------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
| Beginning balance                                         |   | $      | 3,422  |   |   | $      | 4,064  |   |   | $ | 5,061 |   |
| Additions for tax positions related to the current year   |   |   | 786    |   |   |   | 140    |   |   |   | 74 |   |
| Additions for tax positions of prior years                |   |   | 98     |   |   |   | 37     |   |   |   | 292 |   |
| Reductions for tax positions of prior years               |   |   | (652   | )      |   |   | (196   | )      |   |   | (374 | ) |
| Reductions for lapse of applicable statutes of limitation |   |   | (58    | )      |   |   | (623   | )      |   |   | (989 | ) |
| Ending balance                                            |   | $      | 3,596  |   |   | $      | 3,422  |   |   | $ | 4,064 |   |

|                             | April 30, 2010  |   |   | April 30, |   |
|----------------------------------|-----------------|--------|--------|-----------|--------|
| In thousands                     | Effective rates |   |   | 2010      |   |   | 2009 |   |
| Short-term lines of credit       |            |   | 4.30   | %         |   | $ | 1,146 |   |   | $ | 189 |   |
| Revolving credit facility        |            |   | 6.12   | %         |   |   | 45,000 |   |   |   | 67,500 |   |
| Industrial development bonds     |            |   | N/A    |      |   |   | --- |   |   |   | 6,000 |   |
|                             |            |   |   |      |   |   | 46,146 |   |   |   | 73,689 |   |
| Less portion due within one year |            |   |   |      |   |   | (1,146 | ) |   |   | (189 | ) |
| Total long-term debt             |            |   |   |      |   | $ | 45,000 |   |   | $ | 73,500 |   |

----

| Total Funded Debt to Consolidated EBITDA Ratio | ABR Margin(basis points) | LIBOR Margin(basis points) | Commitment Fee (basis points) |
|------------------------------------------------|--------------------------|----------------------------|-------------------------------|
| 3.00x and greater                              | 300.0                    | 400.0                      | 50.0                          |
| 2.25x to less than 3.00x                       | 225.0                    | 325.0                      | 50.0                          |
| 1.50x to less than 2.25x                       | 175.0                    | 275.0                      | 37.5                          |
| 0.75x to less than 1.50x                       | 137.5                    | 237.5                      | 25.0                          |
| Less than 0.75x                                | 100.0                    | 200.0                      | 25.0                          |

| Twelve Month Period Ended       | Covenant       |
|---------------------------------|----------------|
| April 30, 2010                  | Minimum 2.25:1 |
| July 31, 2010                   | Minimum 2.50:1 |
| October 31, 2010 and thereafter | Minimum 3.00:1 |

----

----

| In thousands                                            | Balance Sheet Location          |   | April 30, 2010 |   |   | April 30, 2009 |   |
|---------------------------------------------------------|---------------------------------|--------|----------------|--------|--------|----------------|--------|
| Derivatives designated as hedging instruments:          |                            |   |           |   |   |           |   |
|     Interest rate swap arrangements | Other accrued liabilities  |   | $              | 479    |   |           | $      | 1,181 |   |

| In thousands                                                                                        |   | 2010 |   |   | 2009   |   |
|-----------------------------------------------------------------------------------------------------|--------|------|--------|--------|--------|--------|
| Loss recognized in Accumulated Other Comprehensive Loss before tax effect                           |   | $    | 407    |   |   | $      | 1,181 |   |
| Loss reclassified from Accumulated Other Comprehensive Loss to Interest Expense (effective portion) |   | $    | 1,109  |   |   | $      | 301 |   |

----

|                     | For the Fiscal Years Ended April 30,                                                                                                                                                                                                                                                                                             |      |
|--------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                     | 2010                                                                                                                                                                                                                                                                                                                             | 2009      | 2008 |   |
| Expected option term1    | 5.7 years                                                                                                                                                                                                                                                                                                                        | 5.5 years | 5.9 years |   |
| Expected volatility2     | 70.0%                                                                                                                                                                                                                                                                                                                            | 46.3%     | 51.0% |   |
| Risk-free interest rate3 | 2.3%                                                                                                                                                                                                                                                                                                                             | 3.0%      | 3.2% |   |
| 1                        | The option term was determined using the simplified method for estimating expected option life through December 31, 2007.  The Company's options qualify as "plain-vanilla" options.  Beginning on January 1, 2008, the expected option term is determined by analyzing the Company's historical experience. |      |
| 2                        | The stock volatility for each grant is measured using the weighted-average of historical daily price changes of the Company's common stock over the most recent period equal to the expected option life of the grant.                                                                                                           |      |
| 3                        | The risk-free interest rate is based on the 5-year U.S. Treasury note yield in effect at the time of grant.                                                                                                                                                                                                                 |      |

----

|                                     |  Shares(in thousands) |   |   | Weighted-averageExercisePrice |   | Weighted-averageRemainingContractualTerm |   | AggregateIntrinsicValue(in millions) |   |
|------------------------------------------|----------------------------|--------|--------|-------------------------------|--------|------------------------------------------|--------|--------------------------------------|--------|
| Outstanding as of April 30, 2009         |                       |   | 2,188  |                          |   |                                     | $      | 9.81                                 |   | 5.6 years |   |   | $ | 0.1 |   |
| Options granted                          |                       |   | 100    |                          |   |                                     | $      | 5.72                                 |   |   |   |   |   |   |   |
| Options exercised                        |                       |   | (11    | )                             |   |                                     | $      | 3.35                                 |   |   |   |   |   | --- |   |
| Options cancelled                        |                       |   | (249   | )                             |   |                                     | $      | 11.69                                |   |   |   |   |   |   |   |
| Outstanding as of April 30, 2010         |                       |   | 2,028  |                          |   |                                     | $      | 9.41                                 |   | 5.0 years |   |   | $ | 0.8 |   |
| Options exercisable as of April 30, 2010 |                       |   | 1,633  |                          |   |                                     | $      | 9.69                                 |   | 4.1 years |   |   | $ | 0.6 |   |

|                                                   | For the Fiscal Years Ended April 30, |   |
|--------------------------------------------------------|--------------------------------------|--------|
|                                                   |                                 | 2010   |   |   | 2009 |   |   | 2008 |   |
| Restricted stock awarded (shares in thousands)         |                                 |   | 662 |   |   |   | 767 |   |   |   | 288 |   |
| Weighted-average fair value on date of grant per share |                                 | $      | 6.18 |   |   | $ | 4.52 |   |   | $ | 9.65 |   |

| In thousands except per share amounts |   | Shares |   | Weighted-averageFair Value |   |
|---------------------------------------|--------|--------|--------|----------------------------|--------|
| Nonvested as of April 30, 2009        |   |   | 978    |                       |   | $ | 5.70 |   |
| Granted                               |   |   | 662    |                       |   |   | 6.18 |   |
| Vested                                |   |   | (276   | )                          |   |   | 6.39 |   |
| Forfeited                             |   |   | (112   | )                          |   |   | 5.83 |   |
| Nonvested as of April 30, 2010        |   |   | 1,252  |                       |   | $ | 5.78 |   |

----

| In thousands                 |   | Foreign Currency Translation Adjustment |    | Unrealized Gain (Loss) on Available for Sale Securities |   | Net Gain (Loss) on Derivative Instruments |   | Minimum Pension Liability Adjustment |   | Accumulated Other Comprehensive (Loss) Income |   |
|------------------------------|--------|-----------------------------------------|---------|---------------------------------------------------------|--------|-------------------------------------------|--------|--------------------------------------|--------|----------------------------------------------------|--------|
| Balance as of April 30, 2007 |   | $                                       | 14,435  |                                                    | $      | 12                                        |   | $                                    | ---    |                                               | $      | (13,292 | ) | $ | 1,155 |   |
| Fiscal 2008 activity         |   |                                    | 11,686  |                                                    |   | (486                                      | )      |                                 | ---    |                                               |   | (1,785 | ) |   | 9,415 |   |
| Balance as of April 30, 2008 |   |                                    | 26,121  |                                                    |   | (474                                      | )      |                                 | ---    |                                               |   | (15,077 | ) |   | 10,570 |   |
| Fiscal 2009 activity         |   |                                    | (25,709 | )                                                       |   | 574                                       |   |                                 | (741   | )                                                  |   | (1,973 | ) |   | (27,849 | ) |
| Balance as of April 30, 2009 |   |                                    | 412     |                                                    |   | 100                                       |   |                                 | (741   | )                                                  |   | (17,050 | ) |   | (17,279 | ) |
| Fiscal 2010 activity         |   |                                    | 10,453  |                                                    |   | 590                                       |   |                                 | 440    |                                               |   | (3,585 | ) |   | 7,898 |   |
| Balance as of April 30, 2010 |   | $                                       | 10,865  |                                                    | $      | 690                                       |   | $                                    | (301   | )                                                  | $      | (20,635 | ) | $ | (9,381 | ) |

----

|                                                                                  |   | Qualified Plan |    |   | Nonqualified Plan |   |
|---------------------------------------------------------------------------------------|--------|---------------------|---------|--------|------------------------|--------|
| In thousands                                                                          |   | 2010                |    |   | 2009                   |   |   | 2010 |   |   | 2009 |   |
| Change in benefit obligation:                                                         |   |                |    |   |                   |   |   |   |   |   |   |   |
| Benefit obligation at beginning of fiscal year                                        |   | $                   | 89,612  |   |                   | $      | 103,992 |   |   | $ | 6,608 |   |   | $ | 7,256 |   |
| Service cost                                                                          |   |                | ---     |   |                   |   | 2,289 |   |   |   | --- |   |   |   | 98 |   |
| Interest cost                                                                         |   |                | 6,335   |   |                   |   | 6,622 |   |   |   | 459 |   |   |   | 458 |   |
| Actuarial loss (gain)                                                                 |   |                | 17,396  |   |                   |   | (10,080 | ) |   |   | 974 |   |   |   | (362 | ) |
| Benefits paid                                                                         |   |                | (4,245  | )      |                   |   | (4,151 | ) |   |   | (551 | ) |   |   | (513 | ) |
| Impact of curtailment                                                                 |   |                | ---     |   |                   |   | (9,060 | ) |   |   | --- |   |   |   | (329 | ) |
| Benefit obligation at end of fiscal year                                              |   | $                   | 109,098 |   |                   | $      | 89,612 |   |   | $ | 7,490 |   |   | $ | 6,608 |   |
|                                                                                  |   |                |    |   |                   |   |   |   |   |   |   |   |   |   |   |   |
| Change in plan assets:                                                                |   |                |    |   |                   |   |   |   |   |   |   |   |   |   |   |   |
| Fair value of plan assets at beginning of year                                        |   | $                   | 66,034  |   |                   | $      | 82,197 |   |   | $ | --- |   |   | $ | --- |   |
| Actual return on plan assets                                                          |   |                | 17,311  |   |                   |   | (17,918 | ) |   |   | --- |   |   |   | --- |   |
| Employer contributions                                                                |   |                | ---     |   |                   |   | 5,906 |   |   |   | 551 |   |   |   | 513 |   |
| Benefits paid                                                                         |   |                | (4,245  | )      |                   |   | (4,151 | ) |   |   | (551 | ) |   |   | (513 | ) |
| Fair value of plan assets at end of fiscal year                                       |   | $                   | 79,100  |   |                   | $      | 66,034 |   |   | $ | --- |   |   | $ | --- |   |
| Funded status                                                                         |   | $                   | (29,998 | )      |                   | $      | (23,578 | ) |   | $ | (7,490 | ) |   | $ | (6,608 | ) |
|                                                                                  |   |                |    |   |                   |   |   |   |   |   |   |   |   |   |   |   |
| Amounts recognized in balance sheets, before taxes:                                   |   |                |    |   |                   |   |   |   |   |   |   |   |   |   |   |   |
| Other accrued liabilities                                                             |   | $                   | ---     |   |                   | $      | --- |   |   | $ | (556 | ) |   | $ | (557 | ) |
| Accrued pension benefit liability                                                     |   |                | (29,998 | )      |                   |   | (23,578 | ) |   |   | (6,934 | ) |   |   | (6,051 | ) |
| Net amount recognized                                                                 |   | $                   | (29,998 | )      |                   | $      | (23,578 | ) |   | $ | (7,490 | ) |   | $ | (6,608 | ) |
|                                                                                  |   |                |    |   |                   |   |   |   |   |   |   |   |   |   |   |   |
| Amounts recognized in Accumulated Other Comprehensive Loss, before taxes, consist of: |   |                |    |   |
| Net actuarial loss                                                                    |   | $                   | 31,417  |   |                   | $      | 26,679 |   |   | $ | 1,467 |   |   | $ | 492 |   |

|                                                            |   | Qualified Plan |    | Nonqualified Plan |   |
|-----------------------------------------------------------------|--------|---------------------|---------|------------------------|--------|
| In thousands                                                    |   | 2010                |    |                   | 2009   |   |   | 2010 |   |   | 2009 |   |
| Projected benefit obligation and accumulated benefit obligation |   | $                   | 109,098 |                   |   | $ | 89,612 |   |   | $ | 7,490 |   |   | $ | 6,608 |   |
| Fair value of plan assets                                       |   | $                   | 79,100  |                   |   | $ | 66,034 |   |   | $ | --- |   |   | $ | --- |   |

|                                                           | Qualified Plan                  |   | Nonqualified Plan               |   |
|----------------------------------------------------------------|--------------------------------------|--------|--------------------------------------|--------|
|                                                           | For the Fiscal Years Ended April 30, |   | For the Fiscal Years Ended April 30, |   |
| In thousands                                                   |                                 | 2010   |                                 |   | 2009 |   |   | 2008 |   |   | 2010 |   |   | 2009 |   |   | 2008 |   |
| Service cost                                                   |                                 | $      | ---                                  |   |   | $ | 2,289 |   |   | $ | 2,493 |   |   | $ | --- |   |   | $ | 98 |   |   | $ | 95 |   |
| Interest cost                                                  |                                 |   | 6,335                                |   |   |   | 6,622 |   |   |   | 6,066 |   |   |   | 459 |   |   |   | 458 |   |   |   | 396 |   |
| Expected return on plan assets                                 |                                 |   | (5,264                               | )      |   |   | (6,838 | ) |   |   | (7,044 | ) |   |   | --- |   |   |   | --- |   |   |   | --- |   |
| Amortization of:    Prior service cost (credit) |                                 |   | ---                                  |   |   |   | 296 |   |   |   | 296 |   |   |   | --- |   |   |   | (3 | ) |   |   | (3 | ) |
| Actuarial loss                                                 |                                 |   | 611                                  |   |   |   | 970 |   |   |   | 614 |   |   |   | --- |   |   |   | 42 |   |   |   | 4 |   |
| Curtailment loss (gain)                                        |                                 |   | ---                                  |   |   |   | 507 |   |   |   | --- |   |   |   | --- |   |   |   | (32 | ) |   |   | --- |   |
| Net periodic benefit cost                                      |                                 | $      | 1,682                                |   |   | $ | 3,846 |   |   | $ | 2,425 |   |   | $ | 459 |   |   | $ | 563 |   |   | $ | 492 |   |

----

|                                                                   |   | Qualified Plan |   | Nonqualified Plan |   |
|------------------------------------------------------------------------|--------|---------------------|--------|------------------------|--------|
| In thousands                                                           |   | 2010                |   |                   | 2009   |   |   | 2010 |   |   | 2009 |   |
| Current year actuarial loss (gain)                                     |   | $                   | 5,349  |                   |   | $ | 14,677 |   |   | $ | 974 |   |   | $ | (362 | ) |
| Amortization of net actuarial loss                                     |   |                | (611   | )                      |   |   | (970 | ) |   |   | --- |   |   |   | (42 | ) |
| Amortization of prior service (cost) credit                            |   |                | ---    |                   |   |   | (296 | ) |   |   | --- |   |   |   | 3 |   |
| Effect of curtailment:                                                 |   |                |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Curtailment gain in other comprehensive income             |   |                | ---    |                   |   |   | (9,060 | ) |   |   | --- |   |   |   | (330 | ) |
|   Unrecognized prior service (cost) credit                   |   |                | ---    |                   |   |   | (507 | ) |   |   | --- |   |   |   | 32 |   |
|     Total recognized in other comprehensive income |   | $                   | 4,738  |                   |   | $ | 3,844 |   |   | $ | 974 |   |   | $ | (699 | ) |

| In thousands       | Qualified Plan |   | Nonqualified Plan |   |
|--------------------|---------------------|--------|------------------------|--------|
| Net actuarial loss |                | $      | (732                   | )      |   | $ | (26 | ) |

|                           |   | Qualified Plan |   |   | Nonqualified Plan |
|--------------------------------|--------|----------------|--------|--------|-------------------|
| Benefit Obligation Assumptions |   | 2010           |   |   | 2009              |   |   | 2010 |   |   | 2009 |   |
| Discount rate                  |   |           | 5.80   | %      |              |   | 7.25 | % |   |   | 5.80 | % |   |   | 7.25 | % |

|                           |   | Qualified Plan                  |   |   | Nonqualified Plan               |   |
|--------------------------------|--------|--------------------------------------|--------|--------|--------------------------------------|--------|
|                           |   | For the fiscal years ended April 30, |   |   | For the fiscal years ended April 30, |   |
| Net Cost Assumptions           |   | 2010                                 |   |   | 2009                                 |   |   | 2008 |   |   | 2010 |   |   | 2009 |   |   | 2008 |   |
| Discount rate                  |   |                                 | 7.25   | %      |                                 |   | 6.50 | % |   |   | 6.00 | % |   |   | 7.25 | % |   |   | 6.50 | % |   |   | 6.00 | % |
| Expected return on plan assets |   |                                 | 8.25   | %      |                                 |   | 8.25 | % |   |   | 8.50 | % |   |   | --- |   |   |   | --- |   |   |   | --- |   |
| Rate of compensation increase  |   |                                 | N/A    |   |                                 |   | 4.00 | % |   |   | 4.00 | % |   |   | N/A |   |   |   | 4.00 | % |   |   | 4.00 | % |

----

|                                  |   | April 30, 2010 |   |
|---------------------------------------|--------|----------------|--------|
|   In thousands              |   | Total          |   |   | Quotedprices inactivemarkets(Level 1) |   | Significantotherobservableinputs(Level 2) |   |   | Significantunobservableinputs(Level 3) |   |
| Cash and cash equivalents             |   | $              | 27     |   |   | $ | 27 |   |   | $ | --- |   |   | $ | --- |   |
| Money market funds                    |   |           | 964    |   |   |   | 964 |   |   |   | --- |   |   |   | --- |   |
| Equity securities                     |   |           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   U.S. equity securities    |   |           | 30,778 |   |   |   | 30,778 |   |   |   | --- |   |   |   | --- |   |
|   Foreign equity securities |   |           | 10,324 |   |   |   | 10,324 |   |   |   | --- |   |   |   | --- |   |
|   Global equity securities  |   |           | 2,105  |   |   |   | 2,105 |   |   |   | --- |   |   |   | --- |   |
| Fixed income securities               |   |           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Government securities     |   |           | 12,100 |   |   |   | 12,100 |   |   |   | --- |   |   |   | --- |   |
|   U.S. corporate bonds      |   |           | 16,512 |   |   |   | 16,512 |   |   |   | --- |   |   |   | --- |   |
|   Foreign corporate bonds   |   |           | 541    |   |   |   | 541 |   |   |   | --- |   |   |   | --- |   |
| Real estate mutual fund               |   |           | 5,749  |   |   |   | 5,749 |   |   |   | --- |   |   |   | --- |   |
|     Total         |   | $              | 79,100 |   |   | $ | 79,100 |   |   | $ | --- |   |   | $ | --- |   |

|                                  |   | April 30, 2009 |   |
|---------------------------------------|--------|----------------|--------|
|   In thousands              |   | Total          |   |   | Quotedprices inactivemarkets(Level 1) |   | Significantotherobservableinputs(Level 2) |   |   | Significantunobservableinputs(Level 3) |   |
| Cash and cash equivalents             |   | $              | 21     |   |   | $ | 21 |   |   | $ | --- |   |   | $ | --- |   |
| Money market funds                    |   |           | 2,426  |   |   |   | 2,426 |   |   |   | --- |   |   |   | --- |   |
| Equity securities                     |   |           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   U.S. equity securities    |   |           | 23,212 |   |   |   | 23,212 |   |   |   | --- |   |   |   | --- |   |
|   Foreign equity securities |   |           | 8,825  |   |   |   | 8,825 |   |   |   | --- |   |   |   | --- |   |
|   Global equity securities  |   |           | 1,698  |   |   |   | 1,698 |   |   |   | --- |   |   |   | --- |   |
| Fixed income securities               |   |           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Government securities     |   |           | 10,819 |   |   |   | 10,819 |   |   |   | --- |   |   |   | --- |   |
|   U.S. corporate bonds      |   |           | 15,574 |   |   |   | 15,574 |   |   |   | --- |   |   |   | --- |   |
|   Foreign corporate bonds   |   |           | 434    |   |   |   | 434 |   |   |   | --- |   |   |   | --- |   |
| Real estate mutual fund               |   |           | 3,025  |   |   |   | 3,025 |   |   |   | --- |   |   |   | --- |   |
|     Total         |   | $              | 66,034 |   |   | $ | 66,034 |   |   | $ | --- |   |   | $ | --- |   |

----

|                                 |   | 2010   |   |   | 2009   |   |
|--------------------------------------|--------|--------|--------|--------|--------|--------|
| Equity securities                    |   |   | 55     | %      |   |   | 51 | % |
| Fixed income securities              |   |   | 37     | %      |   |   | 40 | % |
| Real estate                          |   |   | 7      | %      |   |   | 5 | % |
| Other (primarily money market funds) |   |   | 1      | %      |   |   | 4 | % |
|                                 |   |   | 100    | %      |   |   | 100 | % |

| In thousands           | Qualified Plan |   | Nonqualified Plan |   |
|------------------------|----------------|--------|-------------------|--------|
| Fiscal Year 2011       |           | $      | 4,805             |   |   | $ | 556 |   |
| Fiscal Year 2012       |           | $      | 5,256             |   |   | $ | 573 |   |
| Fiscal Year 2013       |           | $      | 5,466             |   |   | $ | 560 |   |
| Fiscal Year 2014       |           | $      | 5,667             |   |   | $ | 589 |   |
| Fiscal Year 2015       |           | $      | 6,037             |   |   | $ | 593 |   |
| Fiscal Years 2016-2020 |           | $      | 33,752            |   |   | $ | 2,924 |   |

| In thousands                       |   | 2010   |   |
|------------------------------------|--------|--------|--------|
| Sign Making and Specialty Graphics |   |   |   |
|   Severance expenses     |   |   | 231    |   |
|   Cash payments          |   |   | ---    |   |
| Ending balance at April 30, 2010   |   |   | 231    |   |

----

| Apparel and Industrial           |   |   |   |   |
|----------------------------------|--------|--------|--------|--------|
|   Severance expenses   |   |   | 639    |   |
|   Cash payments        |   |   | (362   | )      |
| Ending balance at April 30, 2010 |   | $      | 277    |   |
|                             |   |   |   |   |
| Corporate                        |   |   |   |   |
|   Severance expenses   |   | $      | 854    |   |
|   Cash payments        |   |   | (504   | )      |
| Ending balance at April 30, 2010 |   | $      | 350    |   |

| In thousands                              |   | 2009   |   |
|-------------------------------------------|--------|--------|--------|
| Sign Making and Specialty Graphics        |   |   |   |   |
|   Severance expenses            |   | $      | 690    |   |
|   Cash payments                 |   |   | (669   | ) |
| Ending balance at April 30, 2009          |   |   | 21     |   |
|   Cash payments                 |   |   | (21    | ) |
| Ending balance at April 30, 2010          |   | $      | ---    |   |
|                                      |   |   |   |   |
| Apparel and Industrial                    |   |   |   |   |
|   Severance expenses            |   | $      | 1,026  |   |
|   Cash payments                 |   |   | (949   | ) |
| Ending balance at April 30, 2009          |   |   | 77     |   |
|   Cash payments                 |   |   | (77    | ) |
| Ending balance at April 30, 2010          |   | $      | ---    |   |
|                                      |   |   |   |   |
| Ophthalmic Lens Processing                |   |   |   |   |
|   Severance expenses            |   | $      | 148    |   |
|   Cash payments                 |   |   | (148   | ) |
| Ending balance at April 30, 2009 and 2010 |   | $      | ---    |   |
|                                      |   |   |   |   |
| Corporate                                 |   |   |   |   |
|   Severance expenses            |   | $      | 41     |   |
|   Cash payments                 |   |   | (41    | ) |
| Ending balance at April 30, 2009 and 2010 |   | $      | ---    |   |

----

|                                          | For the Fiscal Years Ended April 30, |   |
|-----------------------------------------------|--------------------------------------|--------|
| In thousands                                  |                                 | 2010   |   |   | 2009 |   |
| Beginning balance                             |                                 | $      | 2,815 |   |   | $ | 2,327 |   |
| Warranties issued in the current period       |                                 |   | 5,155 |   |   |   | 5,036 |   |
| Impact of business acquisitions (See Note 5)  |                                 |   | --- |   |   |   | 669 |   |
| Impact of business dispositions (See Note 19) |                                 |   | (574 | ) |   |   | --- |   |
| Reductions for costs incurred                 |                                 |   | (5,146 | ) |   |   | (5,217 | ) |
| Ending balance                                |                                 | $      | 2,250 |   |   | $ | 2,815 |   |

----

|                                               |   | April 30, 2010 |   |
|----------------------------------------------------|--------|----------------|--------|
|   In thousands                           |   | Total          |   |   | Quotedprices inactivemarkets(Level 1) |   | Significantotherobservableinputs(Level 2) |   |   | Significantunobservableinputs(Level 3) |   |
| Available for sale investments                     |   | $              | 3,806  |   |   | $ | 3,806 |   |   | $ | --- |   |   | $ | --- |   |
| Interest rate swap agreements                      |   |           | (479   | ) |   |   | --- |   |   |   | (479 | ) |   |   | --- |   |
| Estimated fair value of contingent consideration   |   |           | (3,174 | )  |   |   | --- |   |   |   | --- |   |   |   | (3,174 | ) |
| Estimated fair value for lease liability guarantee |   |           | (700   | ) |   |   | --- |   |   |   | --- |   |   |   | (700 | ) |
|     Total                      |   | $              | (547   | )  |   | $ | 3,806 |   |   | $ | (479 | ) |   | $ | (3,874 | ) |

|                           |   | April 30, 2009 |   |
|--------------------------------|--------|----------------|--------|
|   In thousands       |   | Total          |   |   | Quotedprices inactivemarkets(Level 1) |   | Significantotherobservableinputs(Level 2) |   |   | Significantunobservableinputs(Level 3) |   |
| Available for sale investments |   | $              | 2,955  |   |   | $ | 2,955 |   |   | $ | --- |   |   | $ | --- |   |
| Interest rate swap agreements  |   |           | (1,181 | )  |   |   | --- |   |   |   | (1,181 | )  |   |   | --- |   |
|     Total  |   | $              | 1,774  |   |   | $ | 2,955 |   |   | $ | (1,181 | ) |   | $ | --- |   |

----

|                                |   | For the Fiscal Years Ended April 30, |    |
|-------------------------------------|--------|--------------------------------------|---------|
| In thousands                        |   | 2010                                 |    |   | 2009 |   |   | 2008 |   |
| Revenue:                            |   |                                 |    |   |   |   |   |   |   |
| Sign Making and Specialty Graphics: |   |                                 |    |   |   |   |   |   |   |
| Gerber Scientific Products          |   | $                                    | 45,141  |   |   | $ | 57,460 |   |   | $ | 68,769 |   |
| Spandex                             |   |                                 | 211,981 |   |   |   | 224,960 |   |   |   | 251,496 |   |
| Sign Making and Specialty Graphics  |   |                                 | 257,122 |   |   |   | 282,420 |   |   |   | 320,265 |   |
| Apparel and Industrial              |   |                                 | 155,145 |   |   |   | 162,965 |   |   |   | 207,945 |   |
| Ophthalmic Lens Processing          |   |                                 | 46,088  |   |   |   | 53,555 |   |   |   | 66,088 |   |
| Consolidated revenue                |   | $                                    | 458,355 |   |   | $ | 498,940 |   |   | $ | 594,298 |   |
| Operating income:                   |   |                                 |    |   |   |   |   |   |   |   |   |   |
| Sign Making and Specialty Graphics: |   |                                 |    |   |   |   |   |   |   |   |   |   |
| Gerber Scientific Products          |   | $                                    | (5,539  | ) |   | $ | (1,078 | ) |   | $ | 1,407 |   |
| Spandex                             |   |                                 | 12,461  |   |   |   | 10,459 |   |   |   | 11,656 |   |
| Sign Making and Specialty Graphics  |   |                                 | 6,922   |   |   |   | 9,381 |   |   |   | 13,063 |   |
| Apparel and Industrial              |   |                                 | 18,342  |   |   |   | 15,352 |   |   |   | 29,177 |   |
| Ophthalmic Lens Processing          |   |                                 | 2,496   |   |   |   | 3,365 |   |   |   | 5,270 |   |
| Segment operating income            |   |                                 | 27,760  |   |   |   | 28,098 |   |   |   | 47,510 |   |
| Corporate operating expenses        |   |                                 | (20,360 | ) |   |   | (21,381 | ) |   |   | (22,722 | ) |
| Consolidate operating income        |   | $                                    | 7,400   |   |   | $ | 6,717 |   |   | $ | 24,788 |   |

----

| In thousands                  | United States |   |    | Europe |   | All Other |    |   | Total  |   |
|-------------------------------|---------------|--------|---------|--------|--------|-----------|---------|--------|--------|--------|
| 2010                          |          |   |    |   |   |      |    |   |   |   |   |   |
| Revenue                       |          | $      | 147,481 |   |   | $         | 209,021 |   |   | $      | 101,853 |   |   | $ | 458,355 |   |
| Property, plant and equipment |          | $      | 17,574  |   |   | $         | 12,847  |   |   | $      | 1,802 |   |   | $ | 32,223 |   |
|                          |          |   |    |   |   |      |    |   |   |   |   |   |   |   |   |   |
| 2009                          |          |   |    |   |   |      |    |   |   |   |   |   |   |   |   |   |
| Revenue                       |          | $      | 175,114 |   |   | $         | 232,717 |   |   | $      | 91,109 |   |   | $ | 498,940 |   |
| Property, plant and equipment |          | $      | 19,020  |   |   | $         | 15,101  |   |   | $      | 2,998 |   |   | $ | 37,119 |   |
|                          |          |   |    |   |   |      |    |   |   |   |   |   |   |   |   |   |
| 2008                          |          |   |    |   |   |      |    |   |   |   |   |   |   |   |   |   |
| Revenue                       |          | $      | 163,099 |   |   | $         | 287,877 |   |   | $      | 143,322 |   |   | $ | 594,298 |   |
| Property, plant and equipment |          | $      | 18,440  |   |   | $         | 17,986  |   |   | $      | 3,426 |   |   | $ | 39,852 |   |

| In thousands | Building andOffice Space |   | Machinery andEquipment |   |   | Total  |   |
|--------------|--------------------------|--------|------------------------|--------|--------|--------|--------|
| 2011         |                     | $      | 9,410                  |   |   | $      | 1,321  |   |   | $ | 10,731 |   |
| 2012         |                     |   | 8,247                  |   |   |   | 1,005  |   |   |   | 9,252 |   |
| 2013         |                     |   | 7,307                  |   |   |   | 620    |   |   |   | 7,927 |   |
| 2014         |                     |   | 6,291                  |   |   |   | 149    |   |   |   | 6,440 |   |
| 2015         |                     |   | 5,093                  |   |   |   | 18     |   |   |   | 5,111 |   |
| After 2015   |                     |   | 12,196                 |   |   |   | ---    |   |   |   | 12,196 |   |
|         |                     | $      | 48,544                 |   |   | $      | 3,113  |   |   | $ | 51,657 |   |

----

|                                              |   | For the Fiscal Year Ended April 30, |
|---------------------------------------------------|--------|-------------------------------------|
| In thousands                                      |   | 2010                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations              |   | $                                   | 5,973 |   |   | $ | 11,601 |   |   | $ | --- |   |
| Pretax income (loss) from discontinued operations | $      | 597                                 |   |   | $ | (1,089) |   |   | $ | --- |   |

|  In thousands                                 |   | September 1, 2009 |   |
|----------------------------------------------------|--------|-------------------|--------|
| Assets:                                            |   |              |   |
| Accounts receivable, net                           |   | $                 | 3,069  |   |
| Inventories                                        |   |              | 3,848  |   |
| Prepaid and other assets                           |   |              | 66     |   |
|      Total current assets |   |              | 6,983  |   |
| Property, plant and equipment, net                 |   |              | 1,336  |   |
|      Total assets         |   | $                 | 8,319  |   |
| Liabilities:                                       |   |              |   |   |
| Accounts payable                                   |   | $                 | 1,142  |   |
| Accrued compensation and benefits                  |   |              | 488    |   |
| Other accrued liabilities                          |   |              | 1,577  |   |
| Other liabilities                                  |   |              | 229    |   |
|      Total liabilities    |   | $                 | 3,436  |   |
| Net assets                                         |   | $                 | 4,883  |   |

----

|                                              |   | For the Fiscal Year Ended April 30, |
|---------------------------------------------------|--------|-------------------------------------|
| In thousands                                      |   | 2010                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations              |   | $                                   | 13,901 |   |   | $ | 32,252 |   |   | $ | 33,920 |   |
| Pretax (loss) income from discontinued operations | $      | (3,427                              | ) |   | $ | (115 | ) |   | $ | 765 |   |

|  In thousands                                 |   | September 30, 2009 |   |
|----------------------------------------------------|--------|--------------------|--------|
| Assets:                                            |   |               |   |
| Accounts receivable, net                           |   | $                  | 4,413  |   |
| Inventories                                        |   |               | 4,579  |   |
| Prepaid and other assets                           |   |               | 174    |   |
|      Total current assets |   |               | 9,166  |   |
| Property, plant and equipment, net                 |   |               | 720    |   |
| Other long-term assets                             |   |               | 60     |   |
|      Total assets         |   | $                  | 9,946  |   |
| Liabilities:                                       |   |               |   |   |
| Accounts payable                                   |   | $                  | 1,332  |   |
| Accrued compensation and benefits                  |   |               | 130    |   |
| Other accrued liabilities                          |   |               | 146    |   |
|      Total liabilities    |   | $                  | 1,608  |   |
| Net assets                                         |   | $                  | 8,338  |   |

|                                     |   | For the Fiscal Year Ended April 30, |
|------------------------------------------|--------|-------------------------------------|
| In thousands                             |   | 2010                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations     |   | $                                   | 1,234 |   |   | $ | 4,206 |   |   | $ | 4,375 |   |
| Pretax loss from discontinued operations | $      | (269                                | ) |   | $ | (1,468 | ) |   | $ | (669 | ) |

|                                              |   | For the Fiscal Year Ended April 30, |
|---------------------------------------------------|--------|-------------------------------------|
| In thousands                                      |   | 2010                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations              |   | $                                   | 2,034 |   |   | $ | 1,827 |   |   | $ | 2,526 |   |
| Pretax income (loss) from discontinued operations | $      | 2                                   |   |   | $ | (216 | ) |   | $ | (278 | ) |

----

|                                              |   | For the Fiscal Year Ended April 30, |
|---------------------------------------------------|--------|-------------------------------------|
| In thousands                                      |   | 2010                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations              |   | $                                   | 3,570 |   |   | $ | 3,988 |   |   | $ | 4,898 |   |
| Pretax (loss) income from discontinued operations | $      | (859                                | ) |   | $ | 407 |   |   | $ | (223 | ) |

|                                       |   | April 30, 2010                    |   |   | April 30, 2009 |   |   | April 30, 2008 |   |
|--------------------------------------------|--------|-----------------------------------|--------|--------|----------------|--------|--------|----------------|--------|
| In thousands except per share amounts      |   | Income from Continuing Operations |   |   | AverageShares  |   |   | PerShare       |   |   | Income from Continuing Operations |   |   | AverageShares |   |   | PerShare |   |   | Income from Continuing Operations |   |   | AverageShares |   |   | PerShare |   |
| Basic earnings per share                   |   | $                                 | 1,342  |   |           |   | 24,961 |           |   | $ | 0.05 |   |   | $ | 4,801 |   |   |   | 24,065 |   |   | $ | 0.20 |   |   | $ | 15,114 |   |   |   | 23,475 |   |   | $ | 0.64 |   |
| Effect of dilutive options and awards |   |                              | ---    |   |           |   | ---    |           |   |   | --- |   |   |   | --- |   |   |   | 74 |   |   |   | --- |   |   |   | --- |   |   |   | 267 |   |   |   | --- |   |
| Diluted earnings per share                 |   | $                                 | 1,342  |   |           |   | 24,961 |           |   | $ | 0.05 |   |   | $ | 4,801 |   |   |   | 24,139 |   |   | $ | 0.20 |   |   | $ | 15,114 |   |   |   | 23,742 |   |   | $ | 0.64 |   |

----

| In thousands except per share amounts |   | FirstQuarter |    |   | SecondQuarter |   |    | ThirdQuarter |   |   | FourthQuarter |   |
|---------------------------------------|--------|--------------|---------|--------|---------------|--------|---------|--------------|--------|--------|---------------|--------|
| Fiscal 2010                           |   |         |    |   |          |   |    |         |   |   |          |   |
| Revenue                               |   | $            | 109,354 |   |          | $      | 118,655 |         |   | $      | 109,185       |   |   | $ | 121,161 |   |
| Gross profit                          |   | $            | 31,858  |   |          | $      | 34,955  |         |   | $      | 32,546        |   |   | $ | 35,274 |   |
| Net income (loss)                     |   | $            | 514     |   |          | $      | 459     |         |   | $      | (809          | )      |   | $ | (1,622 | ) |
| Earnings (Loss) per common share:     |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Basic                                 |   | $            | 0.02    |   |          | $      | 0.02    |         |   | $      | (0.03         | )      |   | $ | (0.06 | ) |
| Diluted                               |   | $            | 0.02    |   |          | $      | 0.02    |         |   | $      | (0.03         | )      |   | $ | (0.06 | ) |
| Fiscal 2009                           |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Revenue                               |   | $            | 146,271 |   |          | $      | 141,030 |         |   | $      | 105,057       |   |   | $ | 106,582 |   |
| Gross profit                          |   | $            | 39,964  |   |          | $      | 41,132  |         |   | $      | 32,019        |   |   | $ | 30,500 |   |
| Net income (loss)                     |   | $            | 681     |   |          | $      | 6,094   |         |   | $      | (2,232        | )      |   | $ | (2,307 | ) |
| Earnings (Loss) per common share:     |   |         |    |   |          |   |    |         |   |   |          |   |   |   |   |   |
| Basic                                 |   | $            | 0.03    |   |          | $      | 0.25    |         |   | $      | (0.09         | )      |   | $ | (0.09 | ) |
| Diluted                               |   | $            | 0.03    |   |          | $      | 0.25    |         |   | $      | (0.09         | )      |   | $ | (0.09 | ) |

----

SIGNATURES

| GERBER SCIENTIFIC, INC. |
|-------------------------|
| (Registrant)            |
|                    |   |   |
| June 30, 2010           |   | By: | /s/  Michael R. Elia                              |
|                    |   |   | Michael R. EliaExecutive Vice President, Chief Financial Officer (Chief Accounting Officer and Principal Financial Officer) |

| Date          | Signature                                      | Title                                                                         |
|---------------|------------------------------------------------|-------------------------------------------------------------------------------|
| June 30, 2010 | /s/ Marc T. Giles(Marc T. Giles)               | President, Chief Executive Officer and Director (Principal Executive Officer) |
|          |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ Donald P. Aiken(Donald P. Aiken)           | Director, Chairman                                                            |
|          |                                           |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ Edward G. Jepsen(Edward G. Jepsen)         | Director                                                                      |
|          |                                           |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ Randall D. Ledford(Randall D. Ledford)     | Director                                                                      |
|          |                                           |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ John R. Lord(John R. Lord)                 | Director                                                                      |
|          |                                           |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ James A. Mitarotonda(James A. Mitarotonda) | Director                                                                      |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ Javier Perez(Javier Perez)                 | Director                                                                      |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ Carole F. St. Mark(Carole F. St. Mark)     | Director                                                                      |
|          |                                           |
|          |                                           |                                                                          |
| June 30, 2010 | /s/ W. Jerome Vereen(W. Jerome Vereen)         | Director                                                                      |

----